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-CHAPTER I 
INTRODUCTION . 
Weil and Stetten (194?) were the first to show that lipid 
mobilizing activity might be demonstrated in the urine during 
fasting. They found that an alkaline extract of urine from 
fasting rabbits when injected into mice caused an increase in 
liver fata similarly prepared extracts of urine from fed rabbits 
had no such effect. 
Chalmers et al. (1958) extended these observations to 
humans. Subjects were fasted for thirty-six hours. From the 
urine collected during the last twenty-four hours of this period, 
a fat-mobilizing material could be precipitated at pH 5·3 with 
two volumes of ethanol. Subs.equent separation, and extraction 
of the material with dilute sodium carbonate solution resulted 
in an alkaline extract which, upon injection into mice, produced 
an increase in liver fat. Animals receiving the urine extracts 
from the same subjects on a normal diet, without fasting •. had 
liver fat values very similar to those found in the saline-
injected animals. 
When the dose of fasting urine extract was varied, the 
increase in liver fat was found to be linearly related to the 
log dose. For convenience, the active material has been referred 
to as Fat Mobilizing Substance (FMS) (Chalmers, 1965). 
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In the intact mouse, subcutaneous injection of FMS caused 
a prompt fall in blood sugar, a rise in blood ketones as well as 
an increase in liver fat (Chalmers et al. 1960). The fall in 
blood sugar preceded the rise in blood ketones. The effect on 
liver fat and blood ketones were maximal at six hours and sub-
sided within twelve hours (Chalmers et al. 1960a). Blood lipids 
including total lipids, phospnolipids, cholesterol and free 
. 
fatty acids also increased six hours after FMS injection 
(Chalmers, 1965). The effects on liver fat and on the circulati g 
levels of lipids and ketone bodies can be considered as the 
results on an increased rate of entry into the liver of free 
fatty acids released from adipose tissue. The following 
evidence support this view: (1) both rats and mice injected 
with FN~ show a prompt rise in plasma free fatty acid concentrat 
ion (Chalmers, 1965); (2) surviving epididymal adipose tissue 
removed from rats previously injected with FMS releases free 
fatty acids faster than tissue from saline-injected animals 
(Chalmers, 1965); (J) addition of FMS to rat adipose tissue in 
vitro causes a marked increase in the rate of release of free 
fatty acids (Chalmers, 1965). This last parameter has been 
utilized as the basis for the measuring the in vitro lipolytic 
activity of FMS. 
Repeated administration of FMS into animals for a period 
of up to three weeks causes weight lossa control animals 
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receiving- saline or non-fasting urine extract do not lose 
weight (Chalmers et al. 1960a). Loss of weight is not due to 
supression of appetites the treated animals remain in good 
condition and their food intake does not differ significantly 
from that of the controls (Chalmers et al. 1960). Carcass 
analysis showed that loss of fat accounts for more than half 
the weight loss; the remainder, being water and body protein, 
is unchanged (Chalmers et al. 1960). 
Kekwick and Pawan (1963) studied the effects of adminis-
tering FMS to mice kept in a metabolic chamber. Respiratory gas 
exchange was measured as well as carbon excretion in stools and 
urine. Daily injections of Ffl'lS caused only a small rise in 
oxygen consumption, carbon dioxide optput did not increase and 
sometimes actually diminished. Carbon balance, however, became 
markedly negative due to increased loss of carbon in the urine 
and, to a lesser extent, in the stools. Similar changes were 
found after daily injections of FMS for three weeks. The form 
in which the additional carbon is excreted is not completely 
clear but it is probably mainly in the form of ketone bodies 
representing the disposal of free fatty acids mobilized in 
excess of energy requirements. These results appear to exclude 
the possibility that FMS, besides releasing free fatty acids 
into the circulation, may directly augment their oxidation in 
peripheral tissues (Chalmers, 1965). Moreover, FMS has been 
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demonstrated to have no effect on the utilization of short-chain 
fatty acids by the isolated perfused rat heart (Chalmers, 1965). 
Following the extraction of FMS from the urine of fasting 
man, Stevenson et al. (1964) reported the extraction of a similar 
material (FMS I) by essentially the same procedure from the 
·urine of fasting rats that also showed -fat mobilizing and hypo-
glycemic properties in vitro ~nd in vivo. FMS I differed from 
the material isolated by Chalmers et al. in that a single 
subcutaneous injection in the rat caused a transient but pro_~_ 
nounced decrease in food intake. Beaton et al. (1964) fraction-
ated FMS I into FMS IA and FMS IB on the basis of solubility 
in alkaline and water solutions. These two fractions were 
chemically distinct1 the anorexigenic property of FMS I 
attributable to the IA component and. the fat mobilizing property 
to the IB component. 
More recently, FMS was extracted from the urine of fastin 
chickens(Nir et al. 1969). The method used to extract FMS was 
essentially that of Chalmers et al. (1958) as modified by 
Stevenson et al. (1964) and Beaton et al. (1964). Injection of 
chicken FMS into chicken caused transient decrease in food intake 
and transient increase in plasma free fatty acids. These effects 
were accompanied by persisting decrease in plasma triglyceride, 
cholesterol and lipid phosphorus • Slight elevation of blood 
glucose occurred but it was not statistically significant. 
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These results, so widely different from those obtained with 
mammals, can only be possible if the process for the metabolism 
of carbohydrate and fats differ widely in chickens and mammals. 
Some data indicate such a possibility. Protamine zinc insulin, 
for example, causes hyperphagia in mammals but, conversely, 
it causes anorexia in chickens (Lepkovsky et al. 1965). More-
over, the FMS from the urine pf fasting chickens has both 
anorexigenic and fat-mobilizing properties that cannot be 
separated into two fractions by the procedure of Beaton et al. 
( 1964) ~ 
FMS activity has also been detected in the urine of fast-
ing mice, dogs, sheep, goats and horses (Kekwick et al. 1967) 
but little information has been reported on the nature of these 
fat-mobilizing materials. 
Conditions in Which FMS Activity Is Found 
FMS activity can be detected in human urine after about 
twelve hours of fasting (Chalmers et al. 1958). In health, no 
activity is detectable with normal unrestricted diets or with 
low-calorie diets provided the daily carbohydrate intake exceeds 
about 80 gms. (Gordon, 1970). 
Chalmers et al. (1960a) reported the effect of progressive 
restriction of dietary carbohydrate in an obese patient. Urine 
was collected on the last two days of each four-day dietary 
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d Diets provided one thousand Calories of which one perio · 
"'" hundred were in the form of protein and 900 as carbohydrate 
plUS fat daily. Urine extracts were assayed for FMS activity 
by the ketogenic effect in mice. At first, when carbohydrate 
provided ninety percent of the remaining calories, no ketogenic 
activity could be detected in the urine. FMS activity began 
to appear in the urine when tne proportion of calories provided 
by carbohydrate was reduced to half and began to increase pro-
gressively with further carbohydrate restriction. This relation-
ship holds true when the diets were given in the reverse order. 
In very obese patients, fasting and low carbohydrate 
diets appear to elicit a smaller output of FMS than in nonobese 
subjects (Chalmers, 1965). It is possible that a primary defect 
of this mechanism plays a part in the development of obesity. 
In contrast, hypothalamic-obese rats excrete a greater amount 
of FMS than do the control animals regardless of whether labor-
atory chow or a high-fat diet is fed prior to fasting (Beaton 
et al. 1966). It would seem that the ability of these animals 
to produce and excrete a substance for mobilizing fat is not 
impaired. Adipose tissue taken from these animals has been 
reported to have a reduced lipolytic response to FMS (Beaton 
et al. l966a). Thus the gain of body fat in these animals may 
be due to an increased food intake and lipogenesis and enhanced 
by a reduced response of their adipose tissue to FMS. 
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Beaton et al. (1965) reported observations on the effects 
of previous diet on excretion of FMS in the urine of fasting 
rats. Four diets (high carbohydrate, hieh protein, high fat 
and high protein-high fat) were investigated and the greatest 
. excretion of FMS was observed when the high protein-high fat 
diet was fed ad libitum prior to fasting. The greatest total 
activity excreted per twenty-four hours was obtained with the 
diet highest in noncarbohydrate calories. 
Chalmers (1965) observed a progressive increase. in.urinar~ 
FMS activity in two lean subjects given a low-calorie, low 
carbohydrate diet for five days. Karninen et al. (1962), howevei, 
have reported results suggesting that less activity is excreted 
on the second day of fasting than on the first day in humans. 
Crisp et al. (1968) suggested that starvation, a powerful 
stimulus for FMS production, if continued without nutrient 
intake, might cause a temporar~ exhaustion of the secretory cell~. 
Beaton et al. (1966) studied the effect of duration of fasting 
peridd on excretion of lipid-mobilizing activity in the urine of 
rats and observed that the greatest excretion of such activity 
occurred in the first twenty-four hours and diminished there-
after up to seventy two hours. These observations seem to con~ 
firm the observations made by Karninen et al. and Crisp et al • 
. 
Braun and Mosinger (1961) reported the urinary excretion 
of a fat-mobilizing substance by rabbits during exposure to 
cold. Beaton et al. (1964a) observed that FMS was excreted by 
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fed rats during acute exposure to cold but not by rats during 
feeding at ambient temperature. Stevenson et al. (1965) 
studied the effect of environmental temperature on the excretion 
of FMS in the urine of fasting rats and observed a progressively 
increasing excretion with decreasing environmental temperature 
from 30° to 5°C. 
The effect of age and sex on the excretion of FMS was 
reported by Beaton et al. (1966). These investigators observed 
that young rats excreted a greater ~ount of FrvJ.S than did adult 
rats, the greatest excretion per ~00 grn body weight being at 
approximately 37 days of age. The amount of FMS excreted did 
not vary apppreciably between 37 and 62 days of age but was 
decreased between 62 and 78 days. It has been generally accept-
ed that puberty in the rat is reached between 50 and 70 days. 
At the age of 27 days, i.e., prepuberty, male rats fed a high-
fat diet excreted more FMS with a higher activity than did 
female rats. However, at 90 days of age (post-puberty), there 
was no apparent sex difference in the amount of total activity 
of FMS excreted per rat but when expressed per 100 gm body 
weight, female excreted more FIVIS than did male .• 
Stevenson and Beaton (1965) observed that infant and 
young children excreted more fat-mobilizing activity than did 
young male adults during an 18 or 24-hour fast. 
FMS has been detected in the urine in a number of clinica 
situations where carbohydrate intake was not severely restricted 
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Activity was found in lipoatrophic diabetes (Chalmers et al. 
196oa, Louis et al. 1960, 1962) and diabetic ketosis (Chalmers, 
1965). Goth et al. (1965) confirmed the presence of FMS in the 
urine of patients with diabetes. In contrast, alloxan-diabetic 
rats excrete less total activity of FMS than do control animals 
(Beaton et al. 1966). 
FMS and Pituitary Hormones 
The ability to produce FMS i~ response to fasting and 
other conditions associated with increased catabolism of fat 
depends on the integrity of the adenohypophysis (or adjacent 
hypothalamus). Chalmers et al. (1960a) reported seven studies 
in six patients with anterior pituitary deficiency. They 
included a patient whose pituitary had been removed for breast 
carcinoma three weeks before, three cases of chromophobe 
adenoma, a patient with Sheehan's syndrome and a woman in whom 
the cause of hypopituitarism was not known. All patients were 
receiving cortisone and thyroid in replacement dosage. No fat-
mobilizing or ketogenic activity was detected in the urine by 
Jn vitr~ or in vivo techniques even though the_patients were 
subjected to severe carbohydrate restriction or fasting for up 
to thirty~six hours. Pituitary-dependence was also demonstrated 
in rats (Beaton et al. 1964a) and in goats (Kekwick et al. 1967). 
Urine extracts from fasting hypophysectomized rats contained no 
fat-mobilizing activity in vitro and in vivq (Beaton et al. 
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1964a). While the urine of fasting, normal and sham-operated 
control animals contained fat-mobilizing activity, no such 
activity could be detected in the urine of hypophysectomized 
goats fasting for up to five days (Kekwick et al. 1967). An 
intact pituitary gland, therefore, appears to be necessary for 
the production of FMS in these mammals. However, the relation-
ship of the pituitary gland and its hormones to the fat-mobiliz-
ing substance of urine is not clear. Whether the pituitary is 
the origin of FMS in mammals or whether, it simply controls the 
formation and release of FMS elsewhere, is not known. 
Comparisons of FMS with lipolytic substances of known 
pituitary origin do reveal important differences1 however. 
Preparations of FMS show weak melanophore-stimulating and in 
vitro corticotrophic activity (Chalmers, 1965) but the evidence 
against the fat-mobilizing property being due to corticotrophin 
or MSH appears to be quite conclusive. Thus comparison of a 
preparation of FMS with corticotrophin A1 peptide gave widely 
differing potency ratios in three assay systems(Chalmers et al. 
1960a). These were (FMS/corticotrophin)a (1) release of corti-
coids by rat adrenal in vitro - 5/1000; (2) release of free 
fatty acids by rat epididymal adipose tissue in vitro - 25/1000; 
(J) increase in blood ketones in intact, unanesthetized mice -
100/1. FMS, unlike corticotrophin, cannot be reversibly 
inactivated with hydrogen peroxide and cysteine (Chalmers et al. 
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196oa). Both calcium and magnesium ions are required for the 
lipolytic effect of corticotrophin in vitroa FMS requires 
calcium but not magnesium (Chalmers, 1964, Beaton et al. 1965, 
1966). Finally both corticotrophin and melanocyte-stimulating 
hormone are lipolytic in the rabbit as well as in the rat 
(Raben et al. 1961) but FMS js inactive in lepo~ine adi.r>ose 
tissue (Chalmers, 1965). Species differences in the responsive-
ness of adipose tissue also differentiate FMS from the lipolytic 
peptides isolated from anterior pituitary glands by Rudma~ et 
al. (1961) and by Friesen et al. (1962), since these substances 
are active in rabbits and ginea pigs but not in rats or mice. 
Administration of commercial corticotrophin to normal subjects 
does. not lead to the appearance of fat-mobilizing activity in 
the urine and the urine of a totally adrenalectomized patient 
with a corticotrophin-secreting pituitary tumor contained no FMS 
while on an unrestricted diet but responded normally to carbo-
hydrate deprivation with excretion of FMS (Chalmers, 1965). 
This ·observation supports the view that FMS is not corticotro-
phin-dependent and shows that functioning adrenal glands are 
not required for the production of activity in response to 
restriction of carbohydrate intake. 
A preparation of FMS tested for thyrotrophic activity 
proved to be inactive (Chalmers, 1965). In one of the two 
thyrotoxic patients, FMS activity was present in non-fasting 
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·ne and disappeared during treatment with carbimazole while ur1 
plasma TSH presumably increased. Therefore, FMS activity could 
not be attributed to TSH (Chalmers, 1965). 
The relationship between FMS and growth hormone remains 
unsettled. The rise in plasma free fatty acids produced by 
~owth hormone is slower than that due to FMS and in vitro, 
growth hormone shows little or no lipolytic activity (Vaughan 
and Steinberg, 196J). Preparations of FMS do not show growth-
promoting activity and do not cross-react with antisera to 
human growth hormone (Chalmers et al. 1960). Chalmers et al. 
(1960a) could find no fat-mobilizing activity in the urine of 
two hypophysectomized patients after injection of human growth 
hormone (5 mg intramuscularly) although plasma free fatty acids 
rose two- to three-fold in each case. 
Interestingly, FMS has been detected in the urine of 
hypophysectomized chickens (Nir et al. 1969). The relationship 
between FMS and hormones of pituitary origin requires elucidatio '• 
Lipolytic Action of FMS 
Factors influencing the in vitro lipolytic action of FMS 
have been studied (Beaton et al. 1966a). Adipose tissue removed 
from rats previously exposed to cold exhibits increased response 
to FMS while adipose tissue of rats rendered hyperphagic and 
obese by bilateral electrolytic ablation of the ventromedial 
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region of the hypothalamus has decreased response. Previous 
feeding of a high-protein diet or a noncarbohydrate high fat 
diet inhibited lipolytic response to FMS in vitro. Of the 
adipose tissues tested, lipolytic response to FMS was in the 
order epididymal) perinephric) omentum. There was no sex 
difference in the response of adipose tissue in vitro. 
Cahill et al. (1961) studied the in vitro effect of fi~S 
on glucose metabolism and observed that FMS increases the 
incorporation of glucose carbon into glyceride-glycerol in the 
same manner as does ACTH, epinephrine and growth hormone (Cahill 
et al. 1960, Lynn et al. 1960 and Leboeuf et al. 1961). These 
workers suggested that FMS primarily accelerates lipolysis and 
does not exert its action via inhibition of esterification. 
The rise in intracellular fatty acids resulting from accelerated 
lipolysis induces increased glucose uptake and glyceride-
glycerol synthesis and increased metabolism of glucose via the 
Embden-Meyerhof pathwar and oxidation by the tricarboxylic 
pathway. 
It would appear that these in vitro observations support 
the in vivo situation. Louis et al. (1962, 1963) reported that 
FMS has strong anti-insulin activity in the dog and suggested 
that the anti-insulin effect may be due to the increased fatty 
acid production since Randle et al. (1963) have shown that 
glucose uptake by muscle is inhibited by increased availability 
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of free fatty acids for oxidation. 
The in vitro relationship between FMS and glucose was 
further studied by Beaton et al. (1966a) who observed that the 
in vitro lipolytic response of FMS can be abolished by addition 
of glucose to the incubation medium. ·It is possible that glucose 
aids triglyceride synthesis resulting in a .net decrease in 
lipolysis. 
In vivo, the hypoglycemic but not the ketonemic effect 
of FMS can be abolished by intraperitoneal injection of glucose 
at the time of FMS injection (Chalmers, 1965). It has been 
shown that the hypoglycemic and fat-mobilizing properties 
of FMS are not mutually dependent and can be dissociated by 
ultrafiltration (Beaton et al. 1966b). 
Mechanism of Action 
The mechanism by which FMS augments the lipolytic reaction 
in rat adipose tissue has been examined in the light of claims 
that all lipolytic agents act by releasing noradrenaline from 
tissue stores (Paoletti et al. 1961). Chalmers (1965) noted 
that most adrenaline-blocking agents when addeq, in vitro, 
depress the lipolytic response to FMS. This is true of nethalide 
as well as dibenzyline, tolazoline and dihydroergotamine. 
Dichloroisoproterenol inhibits the lipolytic effect of FMS to a 
certain degree but its inhibition is far from being complete 
even at high concentration. Adipose tissue removed from rats 
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previously treated with reserpine to deplete tissue stores of 
catecholamines was found to be fully responsive to FMS (Chalmers 
l965). The view that noradrenaline is an essential mediator of 
the lipolytic response to FMS is unsettled. 
Since FMS appears to be a lipolytic agent, it would be 
reasonable to expect its action to be mediated by cyclic AMP 
which is a mediator for many lipolytic agents (Robison et al. 
19?1a). Nathan and LaRoche (1970) suggested that cyclic ~~P 
might be the mediator of the lipolytic response of adipose 
tissue to FMS. At the time the wqr~ described in this dissertat 
ion was initiated (1969), no experimental data had yet been 
presented to support this view. 
Isolation and Purification of FMS 
FMS has been isolated from the urine by a three-stage 
procedure involving• benzoic acid precipitation, extraction 
with water or sodium carbonate solution and alcoholic precipi-
tation (Beaton et al. 1964, Kekwick et al. 1967). Chalmers 
et al. (1960a) reported that the use of oxycellulose increased 
the potency of the isolated product twenty to thirty times 
While Beaton et al. (1966b) reported that millipore filtration 
and carboxymethylcellulose treatment are without any significant 
effect on the activity of the isolated product. Both Beaton 
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et al• (1966b) and Kekwick and Pawan (1967) achieved some 
purification of the material by ultrafiltration through Visking 
dialysis membranes. The greater portion of the activity was 
found in the ultrafiltrate. 
When the ultrafiltrate of the material from the urine of 
fasting rats was further fractionated by passage through a Sepha-
dex G-25 chromatographic column with elution with distilled 
water, three active fractions were obtained (Beaton et al. 1966b) 
These activities did not appear to ~e necessarily associated 
with protein. The first active fraction coincided with the 
presence of carbohydrate although in small amount. The second 
active fraction coincided with the presence of carbohydrate and 
some protein. The third active fraction was associated with 
protein. Consideration of t·hese observations immediately 
raised the question about whether rat FMS contains three separate 
fat-mobilizing substances or whether there is but one compound 
attached to or absorbed by different carrier substances. The 
answer to this question has not yet been secured. 
When the ultrafiltrate of the material from the urine of 
fasting humans was further fractionated by pas~age through a 
column of Sephadex G-50 and then through a column of Bio-Gel 
P-10, a reasonably homogeneous extract was obtained which gives 
a single band when subjected to electrophoresis on polyacryl-
amide gel (Kekwick and Pawan, 1967, Pawan, 1971). 
-17-
Chemical Nature _of FMS 
---- Chalmers et al. (1960a) desc~ibed the Fat-Mobilizing 
Material they had obtained from the urine of fasting humans as 
a polypeptide with molecular weight less than 18,000. It con-
tained about 8% nitrogen and after acid hydrolysis, it yielded 
the following amino acids1 histidine, phenylalanine, leucine, 
serine, cystine, aspartic acid and a trace of alanine. It gave 
a weak Molisch test for carbohydrate. The biological activity 
was thermostable up to 80°C in 0.1 N sodium hydroxide. It was 
destroyed by boiling for two minutes. Activity was completely 
destroyed by digestion with trypsin and chymotrypsin but some 
activity remained after peptic digestion. 
Unpurified fat-mobilizing substance from rat urine was 
reported to contain several amino acids in addition to those 
listed by Chalmers et al. (Beaton et al. 1964). The nitrogen 
contents of human and rat FMS are essentially the same (Beaton 
et al. 1964). Carbohydrate is also nresent irt n,..."!1urified FMS 
obtained from rat urine (Beaton et al. 1964). 
Seifter et al. (1968) after studying the lipid mobilizing 
peptides from various sources suggested that al_l lipid mobilizing 
peptides reported since 1956 are closely related chemically. 
Many questions concerning FMS cannot be answered until it can be 
isolated in pure form. 
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STATEI1IENT OF THE PROBLEM 
- The sequence of events following injection of FMS into 
susceptible animals involvess (1) rise in the concentration of 
free fatty acids within adipose tissue; (2) discharge of these 
acids into the blood, with resultant increase in plasma concen-
tration of free fatty acids which circulate as albumin-free 
fatty acid complexes and (J) uptake and reesterification of a 
proportion of the newly mobilized, circulating free fatty acids 
by liver with resultant fatty liver. 
Most in vivo and in vitro studies on FMS have been focused 
on these aspects and a general agreement has now been reached 
that the primary action of FMS is to increase the concentration 
of free fatty acids within the fat cells, representing an 
acceleration of lipolysis and not a suppression of reesterificat-
ion. Little is known, however, about how FMS acts on fat cells 
to cause this response. 
Reports from many laboratories have shown that adipo-
kinet1c peptides increase the cellular concentration of free 
fatty acids by virtue of activating a "hormone-sensitive" 
lipase within the fat cells thereby accelerating lipolysis 
(Hollenberg et al. 1961, Rizack, 1961, Vaughan et al. 1964). 
Rizack (1964,1965) reported that cyclic AMP in the presence of 
ATP and Mg2+ would 1 1 t th "h · t · " arge y res ore e ormone-sens~ ~ve 
lipase activity which had previously been inactivated by 
incubation of fat pads for J hours prior to homogenization. 
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It is now generally accepted that cyclic ~~p plays a key role 
in hormon~ regulation of lipid mobilization (Vaughan, 1961, 
Klainer et al. 1962, Butcher et al. 1965, Mosinger et al. 1969, 
and Tsai et al. 1970). 
It is the purpose of this dissertation to further purify 
this lipolytic factor, to characterize some. of its chemical 
and biological properties, to investigate the influence of 
various factors which may affect its urinary excretion and its 
in vitro response to adipose tissue and to study the role of 
- . 
cyclic AMP as a mediator in lipolysis stimulated by FMS. It 
is hoped through these means to provide a better understanding 
of the nature and mechanism of action of this biologically 
active principle. 
CHAPTER II 
MATERIAL AND METHODS 
GENERAL EXPERIMENTAL PROCEDURES 
-
In the first part of this work, .the main purpose was to 
develop_a condition under which maximum amount of crude F~~ 
could be obtained per 24 hr. urine collection. Thus adult 
male albino rats were fed different diets, exposed to different 
environmental temperatures and fasted for various periods of time 
prior to urine collection. The conditions under which maximum 
yield of crude FMS was obtained were ·then utilized in the 
development of the isolation procedure. Crude FMS was extracted 
from the urine by a three-stage processa (1) benzoic acid 
· precipitation at pH 5.3; (2) extraction of FMS from the preci-
pitate with distilled waterr (J) alcoholic precipitation at 
pH 5·3· The alcoholic precipitate was lyophilized after solution 
in distilled water. 
At this stage, FMS was assayed in vitro by incubation with 
epididymal fat pads from male rats in a Krebs-Ringer phosphate 
buffer, pH 7.3, containing 4% bovine serum albumin. The in-
creased release of free fatty acids into the medium was taken 
as the index of lipolytic activity. This sometimes presented 
difficulties initially. This may be due to the presence of inhi-
bitory substances that interfered with the assay procedure as 
-21-
indicated by Pawan (1971). It may be due to the inconsistent 
r lipolytic response of adipose tissue to FMS. 
f 
In an attempt to improve the biological assay, epididymal 
fat pads from animals fed different diets, fasted for various 
period of time and subjected to a cold enviromental temperature 
were tested for in vitro lipolytic response to FMS and the 
conditions under which maximum response were exhibited, were 
incorporated into an in vitro bioassay procedure. 
Crude FMS was then partially purified by ultrafilt:t;'ation 
with PM-10 and m1-2 Diaflo membranes and then further fraction-
ated by passage through Sephadex G-50 and BioGel P-10 Chromato-
graphic columns with elution with distilled water. The trans-
mission of the effluent at 280 nm was monitored with a Uvicord 
absorptiometer and recorder and fractions were collected with 
a Savant Fraction Collector. Each fraction was assayed in vitro 
for lipolytic activity and the active fractions were pooled and 
lyophilized. The ·homogeneity of the material obtained at each 
attempted stage of purification was examined by electrophoresis 
utilizing cellulose acetate membranes as well as polyacrylamide 
gel. 
Once purified FMS was at hand, the study of the role of 
cyclic AMP in lipolysis stimulated by FMS was initiated. In 
this part of the investigation, labeled adipose tissue cells 
were prepared and incubated with FMS and method for assaying 
the accumulation of cyclic AMP in isolated fat cells previously 
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labeled with tritiated adenine was utilized. In this assay 
procedure, cyclic AMP is purified from undesired labeled 
nucleotides by barium sulfate treatment and the radioactivity 
in the barium sulfate supernatant is measured by liquid scin-
tillation in a Beckman LS 250 Liquid Scintillation Spectrometer. 
rn order to ensure that the radioactivity measured represented 
cyclic ~JP exclusively, the barium sulfate supernatants were 
examined chromatographically. 
By use of the above procedures, the mechanism by which 
FMS augments the lipolytic reaction in rat adipose tissue was 
studied in light of the current theory that lipolytic hormones 
utilize cyclic AMP as a second messenger to promote the activity 
of hormone-sensitive lipase. 
CHEMICALS 
Acrylamide, Eastman Organic Chemicals, No. 5521 
'Adenine (3H(G)J, 5-15 Ci/mmole, Lot No. 640-126, New England 
Nuclear 
Adenosine 3',5'-Monophosphate, Sigma Chemical Company, No. A9501 
Albumin, Bovine, Fraction V Powder, Sigma Chemical Company, 
No. A4503 
Alcohol, 95%, Commercial Solvents Corporation 
Alcohol, Absolute, Commercial Solvents Corporation 
Ammonium Hydroxide, Mallinckrodt Chemical Works, AR, No. 3256 
l 
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Barbital buffer, Beckman Instruments, Inq., No • .320024 
Barium Hydroxide.8H20, Mallinckrodt Chemical Works, AR, No • .3772 
Benzoic Acid, Aldrich Chemical Company, No. 10,947-9 
Bio-Gel P-10, 50-100 mesh, Bio-Rad Laboratories, No. 81102 
Bio-Solv BBS-J, Beckman Instruments, Inc., No. 18498.3 
BIS (N, N'-Methylene-bisacrylamide), Eastman Organic Chemicals 
No. P 8.38.3 
Bromphenol Blue (Water Soluble), Hartman-Leddon Company, No. 
859 
Calcium Chloride, Anhydrous, Mallinckrodt Chemical Works, AR 
No. 41.32 
Casein, Nutritional.Biochemicals Corporation 
Chloroform, Mallinckrodt Chemical Works, AR, No. 4440 
Collagenase, Type III, Fraction A, Sigma Chemical Company, 
No. C-0255 
Coomassie Brilliant Blue R-250~ Colab Laboratories, Inc., No. 
ll-152B 
Copper Suifate.5H2o, Mallinckrodt Chemical Works, AR, No. 4844 
Crisco, Procter and Gamble Company 
Cupric Nitrate. JH2o, Fisher Scientific Company_, No. 7.3205 
1, 5 Diphenylcarbohydrazide, Eastman Kodak Company, No. 618 
Fiber, Non-nutritive, Nutritional Biochemicals Corporation 
Fixative Dye Solution, Beckman Instruments, Inc., No. J24J40 
Glycine (Ammonia Free), Eastman Organic Chemicals, No. 445 
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Glycerine, Fisher Scientific Company, CR, No. G33 
~, Heptane, Eastman Organic Chemicals, No. 2215 
Hexane, Aldrich Chemical Company, No. 13,938-6 
Hydrochloric Acid, J.T. Baker Chemical Company, No. 9535 
Isopropyl Alcohol, Mallinckrodt Chemical Works, AR, No. 3032 
Liver Powder, Nutritional Biochemicals Corporation 
Magnesium Sulfate.7H20, Mallinckrodt Chemical Works, AR, No. 605t 
Methanol, Anhydrous, Mallinckrodt Chemical Works, AR, No. 3004 
Palmitic Acid, Sigma Chemical Company, No. P-0500 
PPO (2,5-Diphenyloxazole), Beckman-Instruments, Inc., No. 161692 
Potassium Chloride, Granular, Mallinckrodt Chemical Works, AR, 
No. 6858 
Potassium Ferricyanide, Sargent-Welch Scientific Company, AR, 
No. 14180 
Riboflavin, Eastman Organic Chemicals, No. 5181 -
Salt Mix, Wesson Modified Osborne-Mendel, General Biochemicals, 
No. 170900 
Sephadex G-50, Medium, Pharmacia Fine Chemicals Inc. 
Siliclad, Clay Adams Company 
Sodium Carbonate, Anhydrous, Mallinckrodt Chemical Works, AR, 
No. 7521 
Sodium Chloride, Mallinckrodt Chemical Works, AR, No. 7581 
Sodium Hydroxide, Pellets, Mallinckrodt Chemical Works, AR, 
No. 7708 
r 
l 
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Sodium Phosphate Dibasic, Anhydrous, Mallinckrodt Chemical 
Works, AR, No. 7917 
Sucrose, Nutritional Biochemicals Corporation 
Sulfuric Acid, Mallinckrodt Chemical Works, AR, No. 2876 
TElfiliD (N, N, N' ,N'-Tetramethylethylenediamine), Eastman Organic 
Chemicals, No. 8178 
Theophylline, Crystalline, Sigma Chemical Company, No. T-1633 
Thymol, Aldrich Chemical Company, No. 11,209-7 
Toluene, Mallinckrodt Chemical Works, AR, No. 8608 
Trichloroacetic Acid, Mallinckrodt Chemical Works, AR, No. 2928 
TRIZMA-Base, Sigma Chemical Company, No. T 1503 
TRIZIVIA-HCl, Sigma Chemical Company, No. T 3253 
Triethanolamine, Eastman Organic Chemicals, No. 1599 
Trypsin, Type III, from Bovine Pancreas, Sigma Chemical Company 
No. T-8253 
Trypsin Inhibitor, Type II-0, from Ovomucoid (Egg White), Sigma 
Chemical Company, No. T-9253 
Vitamin Diet Fortification Mixture, Nutritional Biochemicals 
Corporation 
Zinc Sulfate.7H2o, J.T. Baker Chemical Company, No.4382 
EXTRACTION OF CRUDE FMS FROM RAT URINE 
Thirty-day old male albino rats were purchased from Loc6k 
Erickson Laboratories, Maywood, Illinois. Crude FMS was ex- · 
• 
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tracted from the urine of these rats according to the method of 
~ Beaton et al. (1964). The pH of the rat urine was adjusted to 
S·3 with N HCl. 10 volumes of a saturated solution of benzoic 
acid in 95% ethanol was slowly added to each 100 volumes of urine 
with constant stirring. Following thorough mixing for 15 
minutes, precipitation was allowed to proce~d overnight at 4°C. 
in a stoppered container. The bulky precipitate which formed 
served to adsorb and coprecipitate FMS from the urine. The 
precipitate was then centrifuged at 15,000 x g at 0° to 5°C. 
in an International Model PR-2 centrifuge and the supernatant 
fluid discarded. 
In order to r~move the benzoic acid, the precipitate 
was washed twice in large centrifuge tubes with cold 95% ethanol 
at pH 5.3, using a glass rod to break up any lumps and mixing 
thoroughly. The ethanolic washings were discarded on each 
occasion after centrifugation. 
FMS was then eluted from the precipitate by adding 100 
ml of distilled water, mixing thoroughly over a period of about 
15 minutes and using a glass rod to break up any lumps. The 
aqueous solution was then centrifuged and the ~upernatant retain-
ed. 
Reprecipitation of FMS was then carried out by adjusting 
the aqueous solution to pH 5·3 with N NaOH or N HCl as required 
and slowly adding 2 volumes of absolute alcohol while constantly 
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stirring with magnetic stirrer. 
. 0 0 
The suspension was left in the cold (4 to 10 C.) for 
the next 24 hrs in a stoppered container for precipitation to 
be completed. The suspension was next centrifuged and the 
supernatant was discarded. To the r~sidue, 50 ml of distilled 
water was added, the slurry was mixed thoroughly and left for 
1.5 minutes to dissolve the FMS. After centrifugation, the 
supernatant solution was lyophilized. The lyophilized product 
(crude FMS) was kept in the refrige:rator in a tightly-stoppered 
container. 
IN VITRO BIOASSAY OF FMS 
The biological activity of FMS was measured by its abili 
to increase the release of free fatty acids (FFA) in vitro 
from epididymal fat pads of the rat in a medium of Krebs-Ringer 
phosphate butfer (pH 7.4) containing 4% bovine serum albumin. 
The amount of FFA released to th~ medium was determined by the 
method of Duncombe (1964), with modifications. In this assay, 
chloroform soluble copper soaps of the FFA are formed and the 
chloroform soluble copper is converted to a co.lored complex by 
treatment with 1,.5 diphenylcarbohydrazide. 
Reagents 
1M Triethanolamine• 14.9 gm of triethanolamine was dissolved 
in distilled water and diluted to 100 ml with distilled water. 
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i·45% Cu(NQ3 ) 2~2oa 6.45 grn of cupric nitrate trihydrate 
was dissolved in distilled water and diluted to 100 ml with 
distilled water. 
1 ,5 Diphenylcarbohydrazide Solutiona 0.5 gm of 1,5 diphenyl-
-
carbohydrazide was dissolved in methanol and the volume was made 
·up to 100 ml with methanol. This solution should be prepared 
just prior to the final steps.of the assay as aging of this 
reagent resulted in increased blank values. 
Copper Reagent: A mixture of equal volumes of 1 M triethanol-
amine and 6.45% cupric nitrate trihydrate solution 
Standard Fatty Acid Solution: Standard solutions of palmitic 
acid ranging from 20 to 120 uM in chloroform were prepared. 
Krebs-Ringer Phosphate Buffer (pH ?.4) Containing 4% Albumina 
Krebs-Ringer phosphate buffer containing the following components 
was prepared: NaCl, 128 mM; Mgso4 , 1.4 mM; CaC12 , 1.4 mM; KCl, 
5.2 ~~ and Na2HPo4 , 10 mM. The phosphate buffer was made 
up fresh daily and the pH adjusted to 7,4 after addition of 
sufficient bovine albumin to yield a 4% (w/v) solution. 
Preparation of Standard Curve 
Approximately 5 ml of standard palmitic acid solutions 
were placed in 18 x 150 mm glass tubes. The solutions were mix-
ed thoroughly with 2.5 ml of copper reagent for 30 seconds 
using a Vortex mixer set at top speed. The two layers were 
allowed to separate and approximately 4 ml of the chloroform 
layer was removed with a 6" , 18 gauge needle and syringe and 
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~fm5ferred to another is x 150 mm tube, care being taken not to 
any of the copper solution. About 2 ml of water was 
the top of the chloroform without mixing. The tubes 
centrifuged in a clinical centrifuge set at top speed for 
1o minutes. The aqueous layer was completely removed along with 
-asmall amount of chloroform layer, with a disposable pipet. 
ThiS step was to insure that any small amount of copper reagent 
remaining in the chloroform layer was removed. Aliquots of 
. . 
1.0 ml of the chloroform solution of the soap were pipetted into 
5 ml volumetric flasks. 1.0 ml of complexing agent, 1,5 diphenyl 
carbohydrazide, was added and the mixtUre was diluted to volume 
with chloroform. The absorbance of each solution at 540 nm was 
read in a Beckman DU Spectrophotometer exactly 5 minutes after 
the addition of the complexing agent. The data for this stand-
ard curve appear in Table 1. A linear relationship between the 
absorbance at 540 nm and the concentration of palmitic acid 
within the range of 4 to 24 uM is shown in Figure 1. 
Determination of the Biological Activity of Fr~ 
An epididymal fat pad weighing 250 mg was placed in a 
25 ml Erlenmeyer flask containing 5 ml of Krebs-Ringer phosphate 
buffer with 4% albumin. After the addition of 100 ugm of mv~ 
(or of a test material) the flask was incubated for 3 hours at 
37°0 in a Dubnoff Metabolic Shaker using air as the gas phase. 
At the end of the incubation, 1.0 ml of the mixture was 
-JO-
Table 1 
Standard Curve Data for Determination of Free Fatty Acids 
No. of 
Determinations Absorbance540nm* Palmitic Acid, YM 
4 .6 O.OJ6 .:!: 0.047 
8 6 0.167 + 0.017 
12 6 0.295 :!: O.OlJ 
16 6 0.425 ± 0.027 
20 6 0.555 ± 0.029 
24 6 0.680 ± 0.02J 
*Mean ± standard deviation 
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PALMITIC ACID CONCENTRATION,uM 
Figure 1. Standard curve for determination of free 
fatty acids· 
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diluted with 1 ml. of distilled water and extracted in a 18 x 
~ 15o mm glass-stoppered centrifuged tube with 5.0 ml. of chloro-
form by mixing for 1 minute on a Vortex mixer set at top speed. 
The mixture was centrifuged in a clinical centrifuge for 20 
minutes. The aqueous and chloroform layers were separated by 
a disc of precipitated protein. 3 ml. of the chloroform solution 
were pipetted into a clean dry tube and analyzed for free fatty 
acids. The concentration of the FFA ·in the medium was calculated 
from the regression line equation of absorbance versus concen-
tration determined by the method of least squares, namely F -
31.06A + 2.82 where F represents the uM concentration of FFA and 
A, the absorbance value. The total FFA released to the medium 
as umoles was calculated by multiplying the value of F by the 
dilution factor. 
PURIFICATION OF CRUDE FiviS BY ULTRAFILTRATION 
A 0.5% aqueous solution of crude FMS was transferred to 
an Amicon Ultrafiltration Cell, Model 52, fitted with a PM-10 
Diaflo membrane. A pressure of 10 psi was applied and the cell 
was stirred at relatively high rate. Ultrafiltration was allow-
ed to proceed for about 1.5 hours at an environmental temper-
ature of 0° to 5°C. During this time, .more than 50% of the fluid 
passed through the ultrafilter. The ultrafiltrate and the 
residue were freeze-dried and bioassayed in vitro for lipolytic 
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activity. 
The biologically active fraction was then subjected to 
ultrafiltration in a like manner using a UM-2 Diaflo membrane. 
~PHADEX G- SO AND BIO-GEL P-10 FRACTIONATION OF' FMS 
A 0.01% aqueous solution of the biologically active fract 
ion from the ultrafiltration with the UM-2 membrane was passed 
through a prepared column (K 25/45 jacked, Pharmacia Fine 
Chemicals Inc., Piscataway, N.J.) of Sephadex G-50 and then 
through a column of Bio-Gel P-10. The temperature of the 
columns was maintained at 0° to 5°C. Elution with distilled 
water was carried out at a rate of 2.5 ml. per minute and serial 
fractions 5 ml. in volume were collected with a Unifrac Fraction 
Collector (Savant Instruments Inc., Hicksville, New York). The 
transmission of the effluent at 280 nm was monitored with a 
Uvicord Absorptiometer and Recorder (LKB Instruments Inc., 
Rockville, Maryland). The total volume of eluate was 500 ml. 
( 100 ·tubes) • Every fourth tube was bioassayed in vitro for 
lipolytic activity. The active fractions were pooled and 
lyophilized. A diagram of the scheme for the extraction and 
purification of FMS is shown in Figure 2. 
MICROZONE ELECTROPHORESIS OF FMS PREPARATIONS 
Reagents a 
Buffer Solution (pH 8.6)a One package of Beckman barbital 
Figure 2. 
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Urine from Fasting Rats 
I pH 8.3 Benzoic Acid 
Benzol c Acid Precipitate 
13X . Ethanol wash 
Residue I Distilled Water 
Water Soluble Fraction 
I pH 8.3 2 Vol. Ethanol 
Alcoholic Precipitate I Di st ilht>d Water 
Aqueous Extract I Lyophilization 
Crude FMS I PM-10 
PM-10 Ultraliltrate I UM-2 
U M- 2 Residue 
10-80 P-10 
Eluate I Lyophilization 
FMS 
Flow diagram for isolation and purification 
of FMS. 
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buffer was dissolved in warm distilled water. After being cooled 
to room temperature, the buffer solution was diluted to one 
liter with distilled water. 
fixative-Dye Solution: The contents of a 30-ml bottle of Beck-
man Fixative-Dye Solution was diluted to 250 ml with distilled 
water. 
Acetic Acid Rinse Solution• Jy. 5% (v/v) solution of acetic acid 
was prepared by diluting 5 ml of glacial acetic aciQ to 100 ml 
with distilled water. 
Clearing Solution: A 25% (v/v) solution of acetic acid in 95% 
ethyl alcohol was prepared by diluting 25 ml of glacial acetic 
acid to 100 ml with ethyl alcohol. This solution must be mixed 
fresh with each filling of the tray. 
Alcohol Rinse Solutiona 95% ethyl a~cohol 
Procedure: The membrane strip (Beckman Instruments, Inc., Cata-
log No. 324330) was first impregnated by floating on the surface 
of, prior to immersion into, the buffer solution. In order to 
remove the excess of buffer, the membrane strip was gently 
pressed between two blotters. It was then clamped onto the 
bridge of the Microzone tank (Beckman Instruments, Inc., Model 
R-101) filled to the mark with the buffer solution. The bridge 
was inserted, the lid attached and the plug was connected to 
the tank. FMS preparations previously dissolved in distilled 
water, were applied ontothe strip with a sample applicator. 
The tank was closed with the covering plate. Electrophoresis 
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was carried out for JO minutes at a constant voltage of 250 
volts. 
After the electrophoretic run, the strip was placed in 
the fixative-dye solution for 5 minutes and then exposed to 
the acetic acid rinse solution until completely destained. 
The strip was then placed in the alcohol rinse solution for 
3 to 5 minutes. It was then placed in the clearing solution 
for another 15 minutes. By using the rubber wiper, the pre-
parate was firmly fitted onto a glass plate free from air 
bubbles and then placed in a 100°C oven for 10 minutes to dry 
the membrane. 
After the glass plate had cooled to room temperature, the 
membrane was peeled off and inserted into a plastic storage 
envelop for scanning and storage. 
GEL ELECTROPHORESIS OF FMS PREPARATIONS 
The polyacrylamide gel electrophoresis unit manufactured 
by the Hoefer Scientific Instruments Company, San Francisco, 
California was utilized. 
Reagents a 
Stock Solutionsa All stock solutions were prepared using de-
ionized water and they were stored in brown bottles in the 
refrigerator. Most of these stock solutions have a shelf-life 
of up to three months. 
Solution Aa J6.J gm of TRIZMA-base and 0.46 ml of TE~ffiD were 
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dissolved in approximately 40 ml of N HCl and the pH of the 
solution was adjusted to 8.9 by titrating with N HCl. Deionized 
water was added to bring up to the volume of 100 ml. 
§plution Ea 5.98 gm of TRIZMA-base and 0.46 ml of TEMED were 
dissolved in approximately 40 ml of N HCl. The pH of the 
solution was adjusted to 6.7 by titrating with N HCl and the 
solution was diluted to 100 ml with deionized water. 
Solution C: JO.O gm of acrylamide, 0.8 gm of ""BIS and 0.015 gm 
of potassium ferricyanide were dissolved in deionized water and 
diluted to 100 ml. 
Solution Dr 10.0 gm of acrylamide and 2.5 gm of BIS were 
dissolved in deionized water and diluted to 100 ml. 
Solution Ea 0.14 gm of ammonium pers~lfate was dissolved in 
deionized water and diluted to 100 ml. 
Solution F: 0.004 gm of riboflavin was dissolved in deionized 
water and diluted to 100 ml. 
101o TCA Solutions 100 gm of trichloroacetic acid was dissolved 
in deionized water and diluted to one liter. 
Coomassie Brilliant Blue Stock Solution; 1 gm of Coomassie 
Brilliant Blue was suspended in 100 ml of deionized water and 
the solution was stirred and filtered through Whatman No. 1 
filter paper. 
Coomassie Brilliant Blue Working Solutiona 1 ml of Coomassie 
Brilliant Blue stock solution was diluted to 20 ml with 10% 
TCA solution. 
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§g]aration Gel Solutions 2 ml of Solution A, 4 ml of Solution 
c, 8 ml of Solution E and 2 ml of deionized water were placed 
in separate flasks and allowed to warm up to room temperature. 
These four components were then added to a single flask and 
swirled gently to prevent air bubble formation and to provide 
th.orough mixing. 
~tacking and Sample Gel Solution: 2 ml of Solution B, 4 ml of 
Solution D, 2 ml of Solution F and 8 ml of deionized water 
were placed in another set of small flasks. These solutions 
were warmed to room temperature and gently mixed in a flask that 
was completely wrapped in foil to protect this gel solution 
from premature photopolymerization. 
Procedure: Twelve acid-cleaned Pyrex glass columns (6.5 em 
long and having an inner diameter of 0.5 em and an outer dia-
meter of 0.7 em) and previously coated with a wetting agent 
(e.g. 1 part Kodak Photo-Flo to 200 parts of water) were placed 
in column base caps (vacutainer tops). The gel columns were the 
placed into a loading rack in which front-to-back vertical 
aligment of the gels could be assured. 
With the use of a 1 ml tuberculin syringe, to which a 
·5 em length of Tygon tubing was attached, exactly 0.8 ml of 
the separation gel solution was dispensed into each of the 
twelve vertical gel columns. Then with an Oxford pipette, 100 
ul of water was carefully layered on top of the gel solution. 
If the gel column had not been coated with a wetting agent 
prior to use, a bolus of water would form which would drop into 
the gel solution and dilute it. If the gel columns are coated, 
water will layer evenly on top of the unpolymerized gel solutions. 
The purpose of the water layering of the gel solution is to 
prevent a gel-air meniscus and to produce a flat gel surface 
which is highly important for obtaining good protein band 
formation. It also prevents oxygen which retards gel formation 
from diffusing into the gels. 
The separation gels were undisturbed for one half pour 
during which time complete chemical polymerization occurred 
as was evident by the visibility of a distinct refractile line 
between the gel and water interface~ 
The columns were then removed from the loading rack and 
the water layer was removed by giving the gel column a quick 
flick of the wrist. The lip of the gel column was then touched 
to a piece of absorbent paper to remove the last traces of 
water. 
Exactly 0.2 ml of stacking and sample gel solution was 
added to each gel column, with the use of a 1 ml syringe as 
before. Once again, 100 ul of water was layered over this 
gel solution as previously described. The entire loading rack 
was then positioned approximately 30 em from a fluorescent 
light source for 15 minutes; at that time photopolymerization 
began as evidenced by the appearance of opalescence in the 
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stacking gel. When photopolymerization had begun, the light 
~, source was moved to about 5 em from the columns and photopoly-
merization was completed in another 15 minutes. The water 
layer was then removed as previously described. 
Exactly 1.5 mg of the FMS preparation to be tested was 
dissolved in 1.0 ml of the stacking and sample gel solution and 
0.2 ml of the solution was added on top of the stacking gel 
• 
and layered with 100 ul of water. The sample gel was allowed 
to photopolymerize for 30 minutes while positioned 5 em from 
the fluorescent light. 
The gel columns were then removed from the loading rack 
and carefully inserted into the holes of the upper bath stoppers 
{sample gel uppermost). Buffer solution was then added on 
top of the sample gels and to. the separation gels such that a 
hanging drop of buffer remained at the bottom of all gel 
columns. It is essential that no air bubbles are entrapped in 
the gel columns. 
·The lower bath {containing the anode) of the Hoefer 
apparatus was then filled with 1000 ml of buffer and the upper 
bath assembly was then carefully placed into position making 
sure that no air bubbles were entrapped at either ends of the 
gel columns. The upper reservoir was then filled with 500 ml 
of buffer solution and 3 to 5 drops of 0.005% bromphenol blue 
was added to serve as a tracking dye. 
The lid was placed on the upper bath and a current of 
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;6 mA (J.O rnA per gel) was applied. Electrophoresis was carried 
out until the front of the now discrete tracking dye had 
to approximately 1/4 inch from the end of the separation 
At the completion of electrophoresis, the gel columns 
were removed from the upper reservoir and immersed in ice-cold 
water for 5 minutes to allow maximal gel contraction. The con-
tracted gel was removed from each column by inserting an 18 
gauge needle, attached to a 10 ml syringe filled with ice-cold 
water, between the glass-column and the sample gel while 
rotating the gel column with one hand and injecting water around 
the gel surface with. the other. The water pressure freed the 
stacking and separating gels and in a few moments the intact 
gel was expelled from the se-parating gel end of the glass 
column. 
The gels were quickly placed in a 10% solution of TCA 
for a minimum of one hour to insure that the protein fractions 
were uniformly fixed. The gels were then stained by immersion 
into 20 ml of the Coomassie Brilliant Blue working solution 
for another hour. Destaining of gels was done by three conse-
cutive immersions of the gels into 10% TCA solution, each im-
mersion lasting about an hour. When the section of a gel, 
containing no separated fraction was completely clear of stain, 
the gel was transferred to a solution comprised of equal parts 
r 
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of glycerol and deionized water. This solution allows for the 
storing of the gels without shrinkage. 
Unstained gels obtained from the electrophoretic run 
on purified FivlS were examined for lipolytic activity by cutting 
the protein segment of each gel. The segments were pooled and 
homogenized in 10 ml of distilled water. The suspension was 
then centrifuged at 20,000 x g for 10 minutes. The supernatant 
was decanted and the homogenized gels were washed three times 
with 5 ml portions of water. The washings and the supernatant 
were combined and lyophilized and the lyophilized product was 
assayed in vitro for lipolytic activity. 
PREPARATION OF ISOLATED FAT CELLS LABELED WITH TRITIATED ADENINE 
Isolated adipose cells labeled with tritiated adenine 
were prepared according to the procedure of Rodbell (1964) as 
modified by Kuo and DeRenzo (1969) and Moskowitz and Fain (1970). 
Method1 10 to 15.gm of rat epididymal fat pads were incubated 
for 1.5 hrs. at 37°C with shaking in a 25 ml siliconized flask 
containing 10 ml of Krebs-Ringer phosphate buffer, pH 7.4 with 
4% (w/V) bovine serum albumin and 10 uCi of adenine-3H (G). 
An additional 10 to 20 uCi of adenine-3H (G) were then added 
to the incubation mixture together with 7 mg of collagenase 
and 4 mg of crystalline trypsin. Cells were isolated by 
digestion with trypsin in addition to collagenase in order to 
diminish the effect of insulin or "insulin-like" substances on 
r 
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the response to lipolytic agents. The digestion was completed 
in about another 40 minutes. The whole digest was then trans-
ferred to a polyethylene centrifuge tube containing 10 ml of 
warm (37°C) albumin-phosphate buffer. Fat cells were liberated 
from the tissue fragments by gentle stirring with a siliconized 
·glass rod. Liberation of cells was manifested by an increased 
turbidity of the medium. Fra&ments of tissue still remaining 
after this treatment were removed with forceps. The. suspended 
cells were centrifuged for 1 minute at 400 x g. The fat cells 
floated to the surface and the stromal-vascular cells were 
sedimented. Fat droplets, which were formed from the breakage 
of the fat cells, floated more rapidly to the surface than the 
fat cells and were aspirated from the surface, after gentle 
stirring the cell suspension. The stromal-vascular cells were 
removed by aspiratinn and the adipocytes were washed by suspendin~:> 
in 10 ml of warm albumin-phosphate buffer and centrifuged for 
1 minute at 400 x g. The washing procedure was repeated three 
times· in order to insure removal of stromal-vascular cells and 
excess tritiated adenine. The cells were finally resuspended 
in an appropriate volume of albumin-phosphate buffer containing 
0.1 mg per ml of trypsin inhibitor to give a cell concentration 
equivalent to 250 mg (wet weight) of epididymal fat pads per 
ml. 
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INCUBATION OF LABELED FAT CELLS WITH LIPOLYTIC AGENTS AND ASSAY 
-
- OF CYCLIC AI...:i.P 
.......-
Labeled adipose cells were incubated with lipolytic 
agents and the accumulation of the cyclic AMP in the medium was 
determined according to the procedure of Krishna et al. (1968). 
in this assay procedure, labeled cyclic AMP was purified by 
addition of zinc sulfate and b~ium hydroxide to precipitate 
all the undesired nucleotides. The radioactivity in ~he barium 
sulfate supernatant was determined. 
Reagen"t,~s 
Dole's Solution 40 parts of isopropyl alcohol, 10 parts of 
hexane and 1 part of N H2so4 were shaken in a 250 ml separatory 
funnel and allowed to come to equilibrium. 
5% Zinc Sulfate Solution 5 gm of Zin9 Sulfate.7H2o were dis-
solved in 100 ml of distilled water. 
Saturated Barium Hydroxide Solution Barium Hydroxide.8H2o 
was added to boiling water until the solution was well saturated. 
The hot solution was filtered through Whatman No. 1 paper, when 
crystal growth was noticed on cooling. 
Procedure& 1 ml of fat cell suspension was transferred to a 
plastic tube (17xl00 mm) containing 4 ml of fresh medium with 
control or experimental additions and incubated for the desired 
time at 37°C in a Dubnoff metabolic shaker using air as the 
gas phase. The incubation was terminated by extraction of the 
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reaction mixture with 2 ml of Dole's solution, followed by 2 ml 
of hexane (Moskowitz and Fain, 1970). The organic and the 
aqueous layers were separated in a 30 ml separatory funnel. 
A portion (1.0 ml) of the organic layer was taken for the 
determination of free fatty acids released to the medium and 
the aqueous layer was collected in a clean 25 ml flask and placed 
in a vacuum oven (Thelco, Prec~sion Scientific Company, Chicago, 
Illinois) for 20 minutes at room temperature to remove residual 
organic solvents. The protein precipitated in the aqueous 
layer was removed by centrifugation. .5 ml of the clear super-
natant were taken and the labeled cyclic ~~P was purified by 
the addition of 1.0 ml of 5% Zinc Sulfate and 0.3 ml of saturated 
barium hydroxide solution to precipitate all the undesired 
nucleotides (Krishna et al. 1968). Tne slurry was centrifuged 
and the supernatant was removed for the determination of 
radioactivity. 
LIQUID·. SCINTILLATION COUNTING 
A 0.2 ml aliquot of the BaSo4 supernatant was placed in 
a liquid scintillation counting vial and to this was added 10 
ml of a toluene-base counting solution. This scintillation 
solution was prepared by dissolving 5 gm of PPO in one liter 
of toluene and to every 100 ml of this solution was added 20 
ml of the Beckman solubilizing reagent Bio-Solv BBS-J. The 
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samPl~were counted in a Beckman LS-250 Liquid Scintillation 
Spectrometer using the automatic quech correction function (AQC). 
A quench correction curve was prepared by adding various amounts 
of cyclic AiviP extracted from isolated fat cells, which had been 
incubated with lipolytic agent and purified by BaS04 precipitat-
10 ml of the toluene fluor containing 105,600 dpm of 
toluene per vial. These samples were counted with the 
Liquid Scintillation Spectrometer using the automatic 
correction. The per cent efficiency was plotted against 
the external standard ratio (Figure J). These data were 
utilized to express the radioactivity measurements in terms of 
disintegrations per minute. 
CHROMATOGRAPHY 
In order to insure that the radioactivity measured repre-
sented exclusively labeled cyclic AMP, the BaS04 supernatants 
from various experimental runs were examined chromatographically. 
The following solvent system was useda isopropyl alcohol, con-
centrated NH40H and water (7ala2). The BaS04 supernatants 
were pooled and lyophilized and the dry material was taken 
up in 0.5 ml of water. 0.1 ml aliquots together with 20 ugm 
of unlabeled cyclic AMP as carrier, were spotted on strips of 
1. 5 x 23" S & S No. 589 paper. Descending chromatography 
Was allowed to proceed for 14 hrs at room temperature. After 
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Figure 3· Quench correction curve for labeled 
cyclic AMP. 
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chromatograms at room temperature, the cyclic AMP 
was located by ultraviolet light and the spot outlined with a 
pencil· The chromatograms were then cut into bands 0.5 em in 
width and the radioactivity was counted in 10 ml of scintillation 
liquid. 
TRYPTIC DIGESTION OF FMS 
Reagents 
-
o.o46 M Tris Buffers 0.557 gm of TRIZMA-base and 0.1671 gm of 
cac12 .2H2o were dissolved in 80 ml of ·distilled water. The pH 
of the solution was adjusted to 8.1 and the volume was diluted 
to 100 ml with distilled water. 
Procedures 7•5 mg of FMS was dissolved in 2.0 ml of Tris Buffer 
pH 8.1 containing 0.0115 M CaC12 • To'this solution was added 
0.3 mg of trypsin. Incubation was carried out at 37°C for 4 
hrs. and the reaction was stopped by addition of sufficient 
li HCl to obtain a pH of 5.0. As controls in this experiment, 
trypsin and CaC12 (without FMS) were incubated. 
Each digest was fractionated into substance greater and 
less than 10,000 in molecular weight by use of a Diaflo ultra-
filtration apparatus fitted with a PM-10 membrane (trypsin, 
2),800; FMS less than 10,000). The filtrate was further 
ultrafiltered with a UM-05 membrane in order to remove salts 
and then lyophilized. Each product was tested for in vitro 
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lipolytic activity using epididymal fat pads. 
CHAPTER III 
EXPERUIENTAL RESULTS 
The experimental portion of this dissertation consists 
of three parts. The first part deals with the extraction of 
crude FMS with maximum yield from the urine of fasting rats and 
the development of an in vitro bioassay procedure with maximum 
sensitivity so that the identity of FMS can be established. The 
second part of this work comprises the purification of the crude 
FMS and the determination of the homogeneity of each lipolytic 
preparation. The third part of the experimental work concerns 
the mechanism by which FMS augments the lipolytic reaction in 
rat adipose tissue. This was studied in light of the current 
theory that lipolytic agents utilize· cyclic AMP as a second 
messenger to promote the activity of the hormone-sensitive 
lipase. 
Effect of Previous Dietary Regimen on the Excretion of FMS 
Four groups of twenty-eight rats each, weighing from 
400 to 450 gm were kept in individual metabolism cages at an· 
environmental temperature of 24° + 1°C. Each group was fed one 
of the four isocaloric experimental diets shown in Table 2 for 
a period of seven days. The animals were then fasted for the 
next 24 hrs during which time urine was collected and pooled 
Table 2 
Constituents and Caloric Content of Experimental Diets* 
High High Noncarbohydrate High 
Constituent Carbohydrate Protein High Fat Fat 
~ Cals/g ~ Cals/g ~ CalsL:g 2f Cals/g 
Casein 18 0.69 64 2.46 18 0.69 18 0.69 
I 
68 2 .6} VI. Sucrose 10 0.39 - - 10 0.39 1--' I 
Crisco 8 0.71 11 1.17 38 3·36 33 2.92 
Non-Nutritive 
- - 9 - 38 - 33 Fiber 
Salt Mixture 4 
-
4 
-
4 
-
4 
Liver Powder 2 
-
2 
-
2 
-
2 
Total 100 4.03 100 4.02 100 4.05 100 4.00 
*Plus 2% vitamins, 
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for each group. Crude FMS was extracted from the urine and 
assayed in vitro for lipolytic activity. 
From the data of Table 3, it is apparent that approxi-
mately equal amounts of crude FivlS were extracted by fasting 
rats previously fed any one of the four diets ad libitum. It 
would appear that increased amount of diet~ry fat and decreased 
amount of dietary carbohydrate are conducive to increased 
excretion of FMS as judged by the increased release of free 
fatty acids per rat. The greatest excretion of FMS was observed 
with animals fed diets providing a large proportion of calories 
from fat. Animals maintained on a high carbohydrate diet 
excreted little or no FMS. The specific activity of this 
material was not significantly different from that of the 
control ( p) 0. 40, paired Student t test). This is in agree-
ment with the observation of Chalmers et al. (1960) that no 
FMS could be detected in the urine of humans subsisting on a 
calorically-restricted diet composed largely of carbohydrate. 
The results of these experiments indicate that a positive 
correlation exists between the lipolytic potency of the 
material excreted and the proportion of calories from fat in 
the diet. These results support the observation of Beaton 
et al. ( 1965) that the extraction of FMS is affected by the 
nature of food prior to fasting. 
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Table .3 
Effect of Previous Dietary Regimen on the Urinary 
Diet 
High 
Carbohydrate 
High 
Fat 
Noncarbohydrate 
High Fat 
High 
Protein 
Excretion of Crude F~~ 
I 
Specific* 
Activity 
O.OJ ± 0.02*** 
0.20 ± 0.01 
0.19 ± 0.02 
0.11 ± 0.02 
mg/rat 
i2. 5 ± 0.4 
1).6 ± 2.1 
12.9 ± 1.9 
14.2 ± 0.9 
Increased** 
release of 
FFA/rat, 
umoles 
J.81 ± 2.16 
27.60 ± 6.20 
24.82 ± 5.68 
15.76 ± .3·.35 
*Increased release (umoles) of free fatty acids (FFA) as a 
consequence of addition of 100 ugm of crude FN~ as compared 
to release in the absence of F1~ 
**Calculated as specific activity x mg of material excreted 
X 10 
***Mean ± standard deviation on three separate urine collections 
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Duration of Fasting on the Urinary Excretion of FMS 
;;...---
28 male albino rats weighing 400-1.!-50 grn were housed in 
metabolism cages and fed a high-fat diet ad libitum. After 
seven days of this adaptation period at room temperature 
(24° + 1°C), the rats were fasted for seventy-two hours at 
room temperature. At the end of each of tbree 24 hr. fasting 
periods, urine was collected and pooled. Crude FiviS was extract-
ed and bioassayed in vitro. In addition, crude FMS was also 
prepared from the urine of animals fed a high-fat diet but 
not fasted. 
It is apparent from Table 4 that crude FMS excreted by 
fed rats had little lipolytic effect in vitro. With fasting, 
there was appreciable excretion of active FMS, the total 
activity being greatest in the first 24 hr. fasting period and 
diminishing thereafter. The sudden increase of excreted acti-
vity may well be related to the coincident mobilization of 
fat in these animals during fasting. It has been often 
observed that in situations in which the mobilization of fat 
from depots is known to occur, there is an increased excretion 
of FMS. The decreased excretion of active FMS noted upon 
prolonged fasting cannot fully be accounted for at this time. 
--55-
Table 4 
Duration of Fasting on Urinary Excretion of Crude FMS 
Fasting 
Period (hrs) 
Fed 
0 - 24 
24 
- 48 
48 
- 72 
Specific* 
Activity 
0.02 + 0. 02*-:~-~-
-
0.21 + 0.05 
0.19 + O.OJ 
0.20 + 0.02 
-
mg/rat 
15.2 + 2.9 
-
14.1 + 2.9 
-
10.9 + 4.4 
-
6.4 + J.4 
-
Increased-l:·->~ 
release of 
FFA/rat, 
umoles 
2.6) + 0.7 
-
29.6 + 6.0 
-
20.7 + 8.4 
-
12.8 + 6.8 
-
*Increased release (umoles) ·of free fatty acids (FFA) as a 
consequence of addition of 100 ugm of crude FMS as compared 
to release in the absence of FMS 
**Calculated as specific activity x mg of material excreted 
per rat X 10. 
*-lH~Mean :t standard deviation, three separate urine collections 
yfect of Enviromental Temperature on Excretion of FMS 
28 male albino rats weighing 400-450 gm were housed in 
metabolism cages and fed a high-fat diet ad libitum. After 
seven days at room temperature (23 + 1°C), the rats were 
fasted for 2L} hrs at each of the following enviromental 
temperature: 5°, 10°, 15°, 25° and 30°C. Urine was collected 
during each fast, pooled for each group and crude FMS was 
extracted and assayed in vitro. 
As shown in Table 5, decreasing the enviromental temper-
ature from 30° to 5°C resulted in an-initial progressive in-
creased excretion of crude F.MS to a maximum at 15°C. The 
sudden and very marked increase in excretion of FMS at 15°C 
is of considerable interest though the cause and significance 
of this increase are not known. It may well be that increased 
spontaneous activity (exercise) or shivering is the causative 
factor in increased excretion of FMS at about 15°C. Exercise 
has been reported-to increase serum concentration of free fatty 
acids (Basu et al. 1960), an index of fat mobilization. All 
urine extracts possessed approximately equal specific lipo-
lytic activity. These results support the observations of 
Braun and Mosinger (1961) and Stevenson et al. (1965) that a 
fat-mobilizing material is excreted in the urine of rabbits 
and rats respectively, when exposed to cold. 
It is apparent from the results of these experiments 
i 
I 
I I 
,I I 
I : 
I I 
-
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Table 5 
Effect of Environmental Temperature on Urinary 
Environmenta6 
Temperature C 
50 
10° 
15° 
20° 
30° 
Excretion of Crude FMS 
Specific·:<-
Activity 
0.18 + 0 • OJ'~HH'r 
0.21 + 0.05 
-
0.20 + 0.02 
-
0.19 + 0.03 
-
0.20 + 0.02 
-
mg/rat 
16.7 + 0.8 
-
27.4 + 0.8 
-
44.1 + 1.0 
-
16.4 + 0.8 
?.5+ 0.4 
Increased~'* 
release of 
FFA/rat, 
umoles 
30.0 ± 0.2 
57·5 + 0.6 
87.7 + 8.9 
-
31.1 + 0.2 
-
15.0 + 1.4 
-
-~~Increased release ( umoles) of free fatty acids (FFA) as a 
consequence of addition of 100 ugm of crude FiviS as compared 
to release in the absence of FMS 
**Calculated as specific activity x mg of material excreted 
per rat x 10 
***Mean + standard deviation, three separate urine collections 
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that the excretion of FMS is affected in quantity by the 
enviromental temperature (Table 5). In contrast, the quality 
but not the quantity of FMS is affected by the nature of the 
food fed prior to fasting (Table J). 
gjfect of Previous Diet on Lipolytic Response of Adipose Tissue 
to FWS 
In this experiment, the lipolYtic effect of FMS was test-
ed on epididymal fat pads taken from thirty-day old rats pre-
viously treated with one of the following diets: high carbo-
hydrate; noncarbohydrate, high fat; high fat and high protein 
diets (Table 2). After seven days on a given regimen, the 
animals were fasted for twenty-four hours and then sacrified 
to obtain the epididymal fat pads. 
Lipolytic response of adipose tissue in the presence 
and absence of FMS was determined and the results appear in 
Table 6. The results of these experiments demonstrated that 
the previous dietary treatment of rats may alter the release 
of free fatty acids by adipose tissue in vitro with the 
absence or the presence of a lipolytic agent. The release of 
free fatty acids in the absence of FMS was essentially the same 
with the tissue obtained from animals fed the high carbohydrate, 
high fat and noncarbohydrate, high fat diets. The release of 
free fatty acids in the presence of FMS was greatest for adipose 
tissues removed from animals previously fed high carbohydrate 
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Table 6 
Effect of Previous Diet on Lipolytic Response of 
Diet 
High 
Carbohydrate 
High 
Fat 
Noncarbohydrate 
High Fat 
High 
Protein 
Adipose Tissue to FMS 
No addition, 
FFA release 
FMS (100 ugm) 
FFA release Response* 
1.91 ± 0.17** 3·71 ± 0.18 1.80 ± 0.16 
2.06 ± 0.12 3·57 ± 0.10 1.51 ± 0.10 
0.46 2.08 ± 0.31 2.54 ± 0.32 + 0.21 
-
0.92 ± 0.10 1.64 + 0.13 
-
0.72 ± 0.11 
*Increased release (umoles) of free fatty acids (FFA) over 
that observed in the absence of added FMS 
**Mean ± standard deviation from six rats 
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and high fat diets. Lipolytic response of adipose tissue to 
FMS was greatest with previous feeding of high carbohydrate 
diet and markedly decreased with the noncarbohydrate, high 
fat diet and the high protein diets. It is quite possible 
that the response of adipose tissue in vitro to other lipolytic 
agents may be similarly affected by the previous dietary regimen 
of the donor animals. The results of these experiments demon-
strated that for the bioassay of the lipolytic activity of 
FMS, the use of epididymal adipose tissue from rats previously 
maintained on a high carbohydrate diet is recommended. 
Effect of the Fasting Period on Lipolytic Response of Adipose 
Tissue to FMS 
24 rats each weighing J00-400 gm were maintained on 
a high carbohydrate diet for seven days. At the end of that 
time, six animals were killed and the remainder were deprived 
of food and were sacrified six at a time after 24, 48 and 
72 hours fastig. Epididymal fat pads were removed and the 
release of free fatty acids by them was me~sured in the presence 
and absence of FI~. The results appear in Table 7• 
The release of free fatty acids in vitro increased with 
prolonged fasting in the presence and absence of FMS. This 
is probably related to the availability of L-o(-glycerophosphate 
derived from glucose metabolism. In the fed state, 
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Table 7 
Effect of Fasting on Lipolytic Response of Adipose 
Fasting 
Period (hrs) 
0 
24 
48 
72 
Tissue to FMS 
No addition, 
FFA release 
1.26 + 0.05** 
1.J5 + 0.12 
1.J9 + 0.08 
2.50 + 0.10 
FMS (100 ug) 
FFA release - Response* 
1.64 + 0.20 0.38 + 0.29 
2.01 + o.4J o.66 + 0.22 
2.55 + O.JO lr16 + 0.05 
. 4.87 + 0.39 2.37 + 0.09 
*Increased release (umoles) of .free fatty acids (FFA) over that 
observed in the absence of added FMS 
**Mean + standard deviation, six rats 
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adipose tissue metabolizes glucose (primarily derived from 
r, dietary carbohydrate) at high rate making available large 
amount of L~-glycerophosphate. Adipose tissue utilizes the 
1~-glycerophosphate and free fatty acids to generate trigly-
ceride so that free fatty acids are not released. In the fasting 
state, however, very little glucose metabolism occurs in the 
adipose tissue and thus there.is little L-~-glycerophosphate 
available for the formation of triglyceride resulting in a 
net increase of lipolysis. Beaton et al. (1966b) reported 
that adipose tissue of fasted rats was much more responsive 
to FMS than was that of fed rats. This response can be almost 
completely abolished by the addition of glucose. The results 
of these experiments were also supported by the observation of 
Buckle and Beck (1962) that glucose added to the medium in-
hibits the lipolytic effect of growth hormone, ACTH and 
adrenal in. 
Lipolytic Response to FMS of Adipos~ Tissue taken from Rats 
Exposed to Cold 
In this experiment, twelve male albino rats weighing 
250-350 gm were housed in metabolism cages and fed a high 
carbohydrate diet ad libitum. After seven days of this adapt-
ation period at room temperature, food was removed and the 
animals were divided into two groups; a control group of six 
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rats was maintained at 24°C and a group of six rats was exposed 
0 to an environmental temperature of 5 C. Both groups of animals 
were killed after seventy-two hours of fasting. Epididymal 
fat pads were removed from each and used for the bioassay of 
F'MS. The results given in Table 8 show that epididymal fat 
pads taken from cold-exposed rats were mor~ responsive to the 
lipolytic action of FMS than were those taken from control 
animals maintained at 24°C. This is expected as fat mobilizatio 
is known to occur when animals are exposed to the cold. In 
addition, previous experiments already demonstrated that ex-
cretion of FMS during fasting increases with lowering of environ 
mental temperature. 
Isolation and Purification of FMS 
Thirty-day old male albino rats weighing 120-180 gm 
were housed in suspended cages in an air-conditioned room. The 
animals were divided into two groups. Thirty rats in one 
group were provided a high fat diet (Table 2) and tap water. 
Three rats in a second group were provided a high carbohydrate 
diet and tap water. After seven days of this adaptation period 
food was removed from both groups of animals. The animals from 
the first group were transferred to stainless steel metabolism 
cages fitted with urine-feces separators and placed in a cold 
room with an environmental temperature of 15°C, Urine was 
collected for the next twenty-four hours in container into 
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Table 8 
Lipolytic Response to FMS of Adipose Tissue Taken 
from Rats Exposed to Cold 
Treatment 
C.ontrol 
Exposed to 
Cold 
No. of 
Determinations 
6 
6 
Response~.:-
75 + 8.6** 
140 + 10.1 
*Expressed as percentage increase of free fatty acids (FFA) 
as a consequence of addition of 100 ugm of FMS 
*{!-Mean + standard deviation 
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which five milliliters of 10% thymol in isopropanol had been 
added. The collected urine was pooled and crude FI\1S was ex-
tracted by the three-stage extraction procedure already describ-
ed. 
The animals from the second group were transferred to 
an enviromental temperature of 0° to 5°C for seventy-two hours 
and were sacrified to obtain the epididymal fat pads which 
would be used for the in vitro bioassay of the FMS preparation. 
The aqueous solution of the crude FMS was purified by 
means of ultrafiltration using a PM-10 Diaflo membrane. The 
filtrate and the residue were each freeze-dried and bioassayed 
in vitro for lipolytic activity. The results of these analyses 
(Table 9) showed that the active material was associated with 
' the filtrate which was, then, further ultrafiltered in the same 
manner through a UM-2 Diaflo membrane. Both the filtrate and 
the retentate were again lyophilized and assayed for activity. 
The activity was found to be associated with the ~1-2 retentate 
which was further fractionated by passage through Sephadex 
G-50 and BieGel P-10 columns with elution with distilled water. 
The elution pattern of the UIVI-2 retentate on Sephadex G-50 
and BioGel P-10 appears in Figure 4. It can be seen that the 
elution peak and the activity peak coincide with each other. 
Therefore, fractions 56 to 98 were pooled, lyophilized and the 
residue assayed in vitro for lipolytic activity. 
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Table 9 
Isolation and Purification of FMS 
Source Material FFA(umoles)-rr P vs Source 
Control 1.38 + 0. 02*•* 
Urine Crude l·58 + 0.01 
FMS 
Crude PM-10 ·2.03.!. 0.02 (0. 001 
FMS Filtrate 
PM-10 1.18 + 0.15 > 0. 400 
Residue 
PM-10 UM-2 0.96 + 0.02 < 0. 010 
Filtrate Filtrate 
UM-2 2.96 + 0.08 < o. 001 
Retentate 
UM-2 FMS 3.88 + 0.12 < 0.001 
-Retentate 
*Expressed as umoles free fatty acids (FFA) released by 100 
ug of test mater~al on 250 mg rat epididymal adipose tissue 
for 3 hrs. at 37 C • 
. **Mean + standard deviation, five determinations 
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The linear dose-response relationships between lipolysis 
and the active fractions are shown in Figure 5· As can be 
seen (Table 9), the activity increased significantly as compared 
with the source along.the line of purification. 
In order to examine the homogeneity of the FMS prepa-
rations, each active fraction w~s subjecte~ to Microzone 
electrophoresis on cellulose acetate at pH 8.6 and the resulting 
electrophoresis patterns appear in Figure 6. FMS migrated as 
a single fast-moving spot while the UM-2 retentate migrated as 
one major fast-moving protein spot and a weakly-staining slow-
moving spot. PM-10 filtrate migrated as three spots, two of 
which v1ere identical to those of the UIVI-2 retentate while the 
third one migrated intermediately to the other two. Crude 
FillS was separated into many .spots, all of which were weakly 
stained. 
The above preparations were further examined for homo-
geneity by polyacrylamide gel electrophoresis and the results 
are shown in Figure 7• FIVIS migrated as a single major protein 
spot. Crude FivlS was separated into four major protein bands 
and many small protein bands. The PM-10 ultrafiltrate was 
separated into two major bandsand numerous small protein bands 
were also observed proximal to the one corresponding to that 
of FMS. UM-2 retentate migrated as a single major protein 
spot together with many small protein bands. It is obvious 
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Figure 5· Dose-response relationship between different preparations 
of FMS and lipolysis. Lipolytic activity in vitro is expressed 
in terms of the increased release {umoles) of free fatty acids {FFA) over that observed in the absence of added FN~ preparations. 
All data points represent the mean of five determinations. 
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that some purification of crude FMS was achieved through 
ultrafiltration and column chromatography. 
In order to verify that the single protein spot observed 
in polyacrylamide gel electrophoresis represented FIVIS, unstained 
gels were examined for in vitro lipolytic activity and the 
analytical data of this experiment appears in Table 10. While 
the non-protein segment of the gel has in vitro lipolytic 
activity comparable to that of the c·ontrol, an increased 
activity was detectable in the protein segment of gels fo~low­
ing electrophoresis at pH 8.J. This activity is not as high as 
that of the original FMS indicating that there was some loss of 
material or activity during the process of electrophoresis but 
it does demonstrate that the single protein spot represents FMS. 
Tryptic Digestion of FMS 
. 
In this experiment, FMS was incubated with and without 
trypsin and trypsin was incubated without FMS in a medium of 
Tris buffer, pH 8.1, containing calcium chloride. Subsequent 
fractionation of the FMS digest with trypsin by ultrafiltration 
using PM-10 and m~-2 Diaflo membranes resulted in a product of 
FMS degradation of molecular weight <10, 000 and ;>500 which was 
biologically inactive (Table 11). When FMS was incubated with-
out trypsin and fractionated in an identical manner, an active 
fraction indistinguishable from that of the original FMS was 
obtained ( p > 0. 4, paried Student t test) . 
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Table 10 
Lipolytic Activity of Unstained Protein Band from 
Polyacrylamide Gel Electrophoresis of FMS at pH 8.3 
Sample 
Control 
Original FMS 
Extract from 
protein segment 
of gels 
Extract from 
nonprotein 
segment of gels 
No. of 
Determinations 
3 
3 
3 
3 
In vitro* 
Lipolytic 
Activity 
1.31 + 0.02** 
3.89 .:t o.o6 
2.31 + 0.12 
1.62"+ 0.02 
*Expressed as umoles free fatty acids released by 100 ug of 
test material ac~ing on 250 mg rat epididymal adipose tissue 
for 3 hrs. at 37 C. 
**Mean .:t standard deviation, three determinations 
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Table 11 
Tryptic Digestion of FI'/lS 
Treatment of FMS No. of In vitro* Determinations Lipolytic 
Activity 
Control 3 1.~0 + 0.06** 
-
Original Fiv1S 3 3·89 + 0.05 
-
Trypsin incubated 3 1.28 + 0.07 (no FMS) -
FMS incubated 3 3.84!. 0.07 (no trypsin) 
FMS incubated with 3 0. 95 + o. 08 
trypsin 
*Expressed as umoles free fatty acids released by 100 ug of 
test material act~ng on 250 mg rat epididymal adipose tissue 
for 3 hours at 37.C. 
**Mean + standard deviations, three separate incubations. 
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When trypsin was incubated without FMS and the digest was 
fractionated in an identical manner, the product after ultra-
filtration showed an in vitro lipolytic activity indistinguish-
able from that of the control system (p>0.4, paired Student 
t test). The results of this experiment indicates that FMS 
is rendered inactive by digestion with trypsin. This observatio 
confirmed the report by Chalmers et al. (1960), who suggested 
that FMS appeared to be a polypeptid~ of undetermined chemical 
nature and amino acid sequence. 
Cyclic AMP Formation and Lipolysis by Isolated Adipose Tissue 
Cells Incubated with FMS 
In this experiment, isolated adipose tissue cells labeled 
with tritiated adenine were prepared and incubated for 30 
minutes at 37°C with varying concentrations of FMS. The 
accumulation of the labeled cyclic N~P in the incubation 
medium as well as the free fatty acids released to the medium 
were determined. The results of this experiment are shown in 
Figure 8 and demonstrate the dose-response relationship between 
concentration of FMS and cyclic AMP levels. 
The adenyl cyclase activity was expressed as the percent-
age of response produced by 300 ug of FMS. Lipolysis was 
measured by determining the free fatty acids released over that 
the absence of FMS. Lipolysis was not observed in spite 
the high cyclic At'\1P levels indicating that the effect of FMS 
cyclic AMP levels was detectable earlier than was lipolysis. 
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Figure 8. Cyclic AMP formation and lipolysis of labeled isolated 
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In order to insure that the radioactivity measured repre-
sented exclusively cyclic Al;IP, the :Baso4 supernatants from 
various runs were pooled. The solution was lyophilized and 
chromatographed over night along with unlabeled cyclic AMP as 
carrier. After locating the cyclic AMP spot by ultraviolet 
light, the chromatogram was cut into 0.5 c~ bands and the radio-
activity of each band was counted by liquid scintillation. 
Figure 9 demonstrates that the radioactivity in the Baso4 super-
natants was concentrated in the area corresponding to that of 
the cyclic M~P carrier. The results of this experiment demon-
strated that the radioactivity measured represented exclusively 
cyclic AMP. 
Kinetics of Cyclic .AIVIP Formation and Lipolysis by Isolated 
Adipose Tissue Cells Incubated with Active and Inactive FMS 
100 ugm of FMS was incubated with labeled adipocytes for 
various periods of time. Cyclic AMP accumulation and the degree 
of lipolysis were measured as before. The adenyl cyclase acti-
vity was expressed as the percentage of the response produced 
by an incubation time of twenty minutes. Paper chromatography 
of BaSo4 supernatant fluid obtained in the assay of adenyl cy-
clase in this experiment also confirmed that the radioactivity 
measured represented exclusively cyclic Al\1P (Figure 10). 
' The accumulation of cyclic AMP reached a maximum at 
about 20 minutes after the adipocytes were exposed to FMS then 
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Figure 9· Paper chromatography of BaS04 supernatant fluid obtained in the adenyl cyclase assay when labeled isolated white 
fat cells were incubated JO min. at J7°C with.FMS. SF 
.represents the solvent front. 
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began to decline thereafter (Figure 11). In contrast, lipolysis 
was detected only about 60 minutes after the addition of FMS 
and it increased steadily thereafter. The results of this 
experiment further demonstrated that cyclic AMP levels were 
elevated before lipolysis was detected in adipose tissue cells 
treated with FMS. 
In order to rule out the possibility of artifacts in the 
system, FMS was inactivated by dissolving in distilled water 
and then boiling for 5 minutes. The FMS solution was coo~ed, 
lyophilized and assayed in vitro for lipolytic activity. The 
lyophilized product was found to be inactive (Tabl.e 12). When 
labeled adipocytes were incubated for 20 minutes with varying 
concentrations of inactive FMS, cyclic AMP levels were not 
elevated (Table 13). 
Effect of Theophylline on Lipolysis by Isolated Adipose Cells 
Incubated with FMS 
· It is well known that theophylline inhibits phosphodi-
esterase which hydrolyzes cyclic M~P to yield M~P. Since FMS 
increases the levels of cyclic AMP and theophylline prevents 
its destruction, a combination of the two should produce a 
synergistic effect at a dosage at which, singly, neither one 
of them can strongly stimulate lipolysis. Therefore, to do 
this experiment, the smallest dose of FMS and of theophylline 
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-Table 12 
Inactivation of FMS by Treatment with Heat 
Material 
FMS 
Heat-treated 
FMS 
No. of 
Experiments 
3 
Lipolytic* 
Activity 
-0.39!. 0.52 
*Increased release (.umoles) of free fatty acids (FFA) as a 
consequence of addition of 100 ug of material acting on 250 
mg rat epididymal adipose tissue for 3 hours at 37°C as 
compared to release in the absence of the material under 
the same experimental conditions. 
**Mean :t standard deviation 
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Table 13 
Formation of Labeled Cyclic AMP by Adipocytes Incubated 
Heat-Treated 
FMS(ug) 
0 
50 
100 
200 
300 
lOO(Active 
with Heat-Treated FMS 
FMS) 
No. of 
Experiments 
3 
3 
3 
3 
3 
3 
Radioactivity 
Representing 
Cyclic AMP 
Levels(dpm) 
807 !. 56* 
529 !. 28 
683 + 42 
790 + 29 
605 + 44 
2483 !. 58 
Note: Absolute amount of cyclic M~P isolated was not determined 
and the radioactivity (dpm) was used to represent the cyclic 
· MIIP levels . 
*Mean + standard deviation 
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that singly will produce a significant measurable and repro-
ducible response had to be established. Figure 12 illustrates 
a linear dose-response relationship between FMS and lipolysis 
up to 125 ug of FMS by isolated adipose tissue cells in a 
medium of Krebs-Ringer phosphate buffer, pH 7·4 containing 
4% of bovine serum albumin. As can be see~, 25 ug of FMS 
produced a measurable and reproducible response in the course 
of 3 hours incubation at J7°C. 
The effect of theophylline on the release of free fatty 
acids under the same experimental conditions is illustrated in 
Figure lJ. A measurable and reproducible response was obtained 
in the presence of 0.25 mM theophylline. 
The effect of 0.25 mM theophylline on lipolysis by iso-
lated adipose cells incubated with 25 ug of FMS is demonstrated 
in Figure 14. It is readily seen that neither 0.25 mM 
theophylline nor 25 ug of FMS strongly stimulate lipolysis, 
but that a combination of the two produces a striking response. 
The potentiation of FMS by theophylline can be taken as good 
presumptive evidence that FMS acts by stimulating adenyl 
cyclase. 
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Figure 12. Dose-response relationship between FMS and lipolysis. 
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increased release (umoles) of free fatty acids (F'F'A) over 
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of 3 hrs incubation. All data points represent the mean ~ 
standard deviation of five determinations. 
I 
co 
\.)"\ 
I 
-·- .·. ·-·· ""*4¢1:; )[ ··11111111111 
~ 
s: 
2.4 
z 
-
> 
1-
-> i= 1. 
(.) 
c( 
(.) 
-
1-0.8 > 
.J 
0 
IL 
-
..J 
0.5 1.0 1.5 2.0 
THEOPHYLLINE, mM 
Figure lJ. Dose-response relationship between th~ophylline and lipolysis. 
Lipolytic activity in vitro is expressed in terms of the 
increased release (urnoles) of free fatty acids (FFA) over 
that observed in the absence of a~ded theophylline during 
the course of J hours incubation. All data points represent 
. the mean~ standard deviation of five determinations. 
. I 
:..:0 
0'-
1 
r' 
0 
a:: 
1- 2.4r-
-> 
z 
-
> I-s: 1.6 ~ 
-1-
~ 
u 
~ 0.8'" 
~ 
2 
J 
0 
-87-
0.25mM 
THEOPHVLLifttE 
25ugm 
FMS 
FMS AND 
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Figure 14 ·• Synergistic effect of FMS and theophylline. 
Lipolytic activity in vitro is expressed in 
terms of the increased release (umoles) of 
free fatty acids (FFA) over that observed in 
the absence of added materials during the 
course of 3 hours incubation. Results are 
given as mean ± standard deviation from five 
determinations. 
CHAPTER IV 
DISCUSSION AND CONCLUSIONS 
A Fat-Mobilizing Substance (FMS) has been detected in the 
urine of man and some other mammalian species, during fasting 
~~d in several other conditions associated with increased 
catabolism of fat. In vivo, this material increases the plasma 
free fatty acids and the turnover rate of fatty acids in adipose 
tissue accompanied by a loss of body fat and body weight without 
a concomitant decrease in food intake and disturbance of nitrogen 
balance. In vitro, FMS increases the ·release of free fatty 
acids from epididymal fat pads into a medium containing bovine 
serum albumin. FMS then is a lipolytic agent. It appears to 
be a low molecular weight polypeptide but its precise chemical 
nature and mechanism of action have not yet been determined. 
From the information provided by previously reported studies 
on many lipolytic agents that utilize cyclic AMP as a second 
messenger to promote lipolysis in adipose tissue cells (Butcher 
et al. 1965, 1967, Hynie et al. 1966, Weiss et al. 1966 and 
Humes et al. 1968), it appeared that cyclic AMP would also play 
an important role in lipolysis stimulated by FMS. 
This study was concerned with further purification and 
characterization of this lipolytic factor and the role of cyclic 
~~P as a possible mediator in iipolysis stimulated by FMS. 
In the first part of this study, FMS was prepared accordine 
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the current method which involves benzoic acid precipitation 
Fr.rs from the urine of fasting rats, water extraction and 
alcoholic precipitation. In order to develop a condition under 
which maximum amount of crude FMS could be obtained per 24 hr. 
urine collection, JO day old male albino rats were fed different 
diets, exposed to different environmental temperatures and fasted 
for various periods of time prior to urine collection. The 
results obtained in this investigation compared favorably with 
those previously reported (Beaton et al. 1966) and indicated that 
FliTS can best be extracted from the first 24 hour urine collection 
of rats that were fed a high fat diet for 7 days and then fasted 
at an environmental temperature of 15°C during which time,· urine 
was collected and pooled. 
The current in vitro method for the determination of the 
lipolytic activity of FMS, as well as for many other adipo-
kinetic substances involves the incubation of the material with 
isolated rat adipose tissue under physiological conditions in 
the presence of bovine serum albumin and the quantitative esti-
mation by the titration method of Dole (1956) of the free fatty 
acids released to the incubation medium. The condition of the 
animals from which the adipose tissue is obtained has to be 
delineated. For this reason, epididymal fat pads from animals 
fed different diets, fasted for various periods of time and 
subjected to a cold environmental temperature were tested for 
in vitro lipolytic response to Ff/IS. The experimental results 
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indicated that animals fed a high carbohydrate diet and then 
st~~ved for 72 hours at 0° to 5°C prior to sacrifice would 
provide epididymal fat pads with maximum response to FMS. 
The colorimetric method developed by Duncombe (1964) 
was adopted throughout for the quantitative determination of 
free fatty acids released to the medium. This is a simple and 
rapid method and is sensitive. 
In the in vitro bioassay of FMS, some investigators have 
employed Krebs-Ringer bicarbonate buffer, pH 7. 4 as the ir:J.Cu-
bation medium with air as the gas phase. Studies done with 
bicarbonate buffer must be done with 5% co2 in the gas phase 
otherwise the final pH of the medium will be around 8.2 to 8.4 
(Fain, 1973), a circumstance under which there is a marked in-
crease in basal glucose metabolism, resulting in reesterification 
of free fatty acids due to the availability of the L~·glycero­
phosphate (Gliemann, 1967). For convenience then, Krebs-Ringer 
phosphate buffer was used with air as the gas phase in all the 
experiments in this dissertation. 
The most commonly used gel filtration techniques for the 
separation and fractionation of biological materials require 
some knowledge of the molecular size of the material for proper 
selection of chromatographic conditions. 
Chalmers et al. (1960) described FMS as a polypeptide 
with molecular weight less than 18,000 while Beaton et al. 
(1966) reported that ultrafiltration removed inactive substances 
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with a molecular weight exceeding 30,000. Undoubtedly, the 
approximate molecular weight of the active substance can be 
obtained by using Diaflo ultrafiltration. Therefore, crude F~~ 
. 
was first fractionated into substances greater than and less 
than 10,000 molecular weight by use of a Diaflo ultrafiltration 
apparatus fitted with a Piv1-10 membrane. Subsequent in vitro 
bioassay indicated that the fraction with molecular weight 
>10,000 did not possess fat-mobilizing activity. When the 
active fraction was further fractio~ated .in the same manner 
through a UM-2 Diaflo membrane, with a cut-off at 1,000 in 
- . . 
molecular ~eight, it was found that the active material was 
associated with the UM-2 retentate. Thus it is evident that 
the a.ctive material as isolated from rat urine has a molecular 
weight between 1,000 to 10,000. 
Beaton et al. (1966) reported that fractionation of 
their ultrafiltrate on Sephadex G-25 demonstrated the presence 
of three active fractions associated with the ultrafiltrate. 
The first active fraction coincided with the presence of carbo-
hydrate while the second active fraction coincided with the 
presence of carbohydrate and some protein. The third active 
fraction coincided with some protein. However, when the Uivl-2 
retentate was fractionated by passage through a Sephadex G-25 
column with elution with distilled water, the activity was found 
to be associated only with the first ten 5 ml fractions. Thus 
the results of the experiment suggest that the active material 
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have a molecular weight > 5,000. 
Pawan (1971) indicated that some purification of FMS can 
be achieved by passage through a column of Sephadex G-50 and 
then through a column of Bio-Gel P-10. When the m~-2-retentate 
was subjected to these two chromatographic columns with elution 
with distilled water, the activity peak anq the elution peak 
representing the transmission of the effluent at 280 nm, were 
found to coincide with each other. 
The results of this experiment seem to suggest that the 
active material is associated with protein. However, it is 
possible that the protein is present as an inert carrier and 
cannot be dissociated from active FlVIS by ultra• and gel-fil-
trations under the present experimental conditions. This possi-
bility, however, is ruled out since FMS is inactivated by 
digestion with trypsin. It is now clear that FlVIS prepared and 
purified under the present experimental conditions is a poly-
peptide with a molecular weight between 5,000 and 10,000. 
· The homogeneity of the preparations of FMS had to be 
established. This was achieved by subjecting the isolated 
preparations which displayed lipolytic activity to cellulose 
acetate and polyacrylamide gel electrophoresis. A single major 
protein spot was obtained from the purified FMS preparation with 
both electrophoretic techniques. That the single major protein 
spot represented FMS was demonstrated since the aqueous extract 
prepared from the relevant segment of unstained polyacrylamide 
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gels exhibited in vitro'lipolytic activity. 
In studying the role that cyclic AMP plays in the lipo-
lytic reaction of FMS, isolated fat cells were used in place of 
intact epididymal fat pads because of the heterogeneity of the 
cell population found in fat pads (Butcher and Baird, 1968) and 
the increased sensitivity of isolated fat cells to lipolytic 
agents (Fain et al. 1972). The increased sensitivity may be 
due to the uncovering of the receptor·sites during the isolation 
of fat cells, the removal of inhibitory materials and the 
greater ease of access of the lipolytic agents to the receptor 
sites (Fain et al. 1972). 
The experimental approaches used in this study were to 
satisfy some of the criteria established by Robison et al. 
(1971) to justify a claim that a given hormone stimulates 
adenyl cyclase. The present findings demonstrated that FMS was 
capable of increasing the intracellular cyclic AMP levels in 
intact isolated fat cells while inactive FivlS (heat treated FMS, 
proven·to be inactive) did not increase cyclic AMP levels. 
Furthermore, the cyclic AMP levels were elevated before lipo-
lysis was detected in cells treated with FMS. This is con-
sistent with the suggestion of previous investigators (Butcher 
and Sutherland, 1962) that cyclic &~P is the cellular mediator 
of hormone actions and may be related to the lipolytic cascade 
proposed by Steinberg (1971). Thus, after FMS stimulation 
of the adenyl cyclase system, cyclic AMP activates protein 
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kinase which in turn phosphorylates the hormone-sensitive 
lipase, converting it from a less active to a more active form. 
It is this form of the enzyme that control the lipolysis of 
triglyceride to free fatty acids. 
The potentiation of FMS by theophylline, a phosphodiester 
ase inhibitor, was also demonstrated. Neither 0.25 ~~ 
theophylline nor 25 ug of FMS strongly stimulated lipolysis, 
but a combination of the two produced a striking response. 
The potentiation of FMS by theophylline can be taken as good 
presumptive evidence that FMS acts by stimulating adenyl 
cyclase (Robison et al. 1971). 
BIBLIOGRAPHY 
Basu, A., Passmore, R. and Strong, J.A. (1960) The effect of 
exercise on the level of non-esterified fatty acids in the blood. 
Quart. J. Exp. Physiol. ~. 312-317 
.Beaton, J.R.,Szlavko, A.J. and Stevenson, J.A.F. (1964) 
Extraction and chemical characterization of anorexigenic and 
fat-mobilizing substances from rat urine. Can. J. Physiol. 
Pharmacal. 42, 647-655 
Beaton, J.R., Szlavko, A.J., Box, B.M. and Stevenson, J.A.F. 
(1964a) Biological effects of anorexigenic and fat-mobilizing 
substances from rat urine. Can. J, Physiol. Pharmacal. 42, 
657-664 
Beaton, J.R., Szlavko, A.J., Borre, A.J. and Stevenson, J.A.F. 
(1965) Diet and temperature effects on excretion of fat-
mobilizing sunstance in rat urine. Proc. Soc. Exp. Biol. Med. 
118, 362-365 
Beaton, J.R., Szlavko, A.J. and Stevenson, J.A.F. (1966) Factor 
influencing the excretion of a fat-mobilizing substance in the 
urine of rats. Can. J. Physiol. Pharmacal. 44, 95-101 
Beaton, J.R., Szlavko, A.J. and Stevenson, J.A.F. (1966a) 
Observations on the lipolytic action in vitro of a fat-mobilizin 
substance extracted from urine of fasting rats. Can. J. Physiol. 
Pharmacal. 44, 103-113 
Beaton, J.R., Szlavko, A.J. and Stevenson, J.A.F. (1966b) 
Purification by ultrafiltration of a fat-mobilizing substance 
extracted from the urine of fasting rats. Can. J. Physiol. 
Pharmacal. 44, 701-709 
Braun, T. and Mosinger, B. (1961) Nektere humoralini faktory V 
regulaci tukoveho metabolismu~ Acta Inst. Nutr. Hum. Pragae, 
], 74-75 
-96-
Buckle, R.M. and Beck, J.C. (1962) Modifying influence of 
glucose on fatty acid-mobilizing activities of epinephrine, 
ACTH and growth hormone in vitro. Metabolism, 11, 235-244 
Butcher, R.W. and Sutherland, E.W. (1962) Adenosine 3', 5'-
phosphate in biological materials. J. Biol. Chern. £11, 
1244-1250 
Butcher, R.W., Ho, R.J., Meng, H.C. and Sutherland, E.W. (1965) 
Adenosine 3' ,5'-monophosphate in biological materials. J. 
Biol. Chern. 240, 4515-4523 
Butcher, R.W. and Sutherland, E.W. (1967) The effects of the 
cate?hola~ines, adr~ner~ic blocki~g agents, pr?s~aglandin. E1 and 1nsul1n on cycl1c AMP levels 1n the rat ep1d1dymal fat 
pads in vitro. Ann. N.Y. Acad. Sci. 1J2, 849-859 
Butcher, R.W. and Baird, C.E. (1968) Effects of prostaglandins 
on adenosine 3',5'-monophosphate le~els in fat and other 
tissues. J. Biol. Chern. 243, 1713-1717 
Cahill, G.F., Jr., Leboeuf, B. and Flinn, R.B. (1960) Studies 
on rat adipose tissue in vitro. J. Biol. Chern. ~. 1246-1250 
Cahill, G.F., Jr., Pawan, G.L.S. and Chalmers, T.M. (1961) 
Effects of fat-mobilizing extract from human urine on metabolism 
of glucose in rat adipose tissue. Endocrinology §.2, 648-651 
Chalmers, T.M., Kekwick, A., Pawan, G.L.S. and Smith, I. (1958) 
On fat-mobilizing activity of human urine. Lancet 1, 866-869 
Chalmers, T.M., Pawan, G.L.S. and Kekwick, A. (1960) Fat-
mobilizing activity of human urine extract. Amer. J. Clin. 
Nutr. 8, 728-732 
Chalmers, T.M., Pawan, G.L.S. and Kekwick, A. (1960a) 
mobilizing and ketogenic activity of urine extractsJ 
to corticotrophin and growth hormone. Lancet 2, 6-9 
\ 
Fat-
Relation 
-97-
Chalmers, T.M. (1964) Lipolytic factor from human urine. In 
L'Obesite, edited by Klotz, H. Parisa L'Expanson Scientifique 
pp 20-38 
Chalmers, T.M. (1965) Lipid mobilizing activity during fasting. 
In Handbook of Physiology, Section 5~ Adipose Tissu~, edited 
by Renold, A.E. and Cahill, G.F., Jr. Waverly Press Inc., 
Baltimore, Md. pp 549-555 
Crisp, A.H., Blendis, L.M. and Pawan, G.L.S. (1968) Aspects 
of fat metabolism in anorexia. nervosa. Metabolism 11., 
1109-1118 
Dole, V.P. (1956) A relation between non-esterified fatty acids 
in plasma and the metabolism of glucose. J. Clin. Invest. 
J.2, 150-154 
Duncombe, W.G. (1964) The colorimetric micro-determination of 
non-esterified fatty acids in plasma. Clin. chim. Acta 2• 
122-125 
Fain, J.N. (1973) Personal communications Isolation of free 
brown and white fat cells, Methodsin Enzymology- Lipids, 
Chapter in preparation. 
Fain, J.N. and Rosenberg, L. (1972) Antilipolytic action of 
insulin o~ fat cells. Diabetes 21, 414-425 
Fries·en, H., Irie, M. and Barrett, R.J. (1962) An immunologic 
study of two metabolically active peptides from the anterior 
pituitary gland. J. Clin. Exp. 16, 787-796 
Gliemann, J. (1967) Assay of insulin-like activity by the 
isolated fat cell method. Diabetologia ], 382-388 
Gordon, E.S. (1970) Metabolic aspects of obesity. In Advances 
in Metabolic Disorders, edited by LaVine, R. and Luft, R. 
Academic Press, N.Y. pp 229-296 
-98-
Goth, A. and Hegedus, A. (1965) FMS in the urine of patients 
with diabetes and with pituitary diseases, and the effect of 
insulin on its action. Experientia (Basel) £1, 277-278 
Hollenberg, C.H., Raben, M.S. and Astwood, E.B. (1961) The 
lipolytic response to corticotrophin. Endocrinology 68, 
589-598 
~umes, J.L., Mandel, L.R. and Kuehl, F.A., Jr., (1968) Studies 
on the mechanism of antilipolytic action of prostaglandin E 
in vitro. In Prostaglandin Symposium of the Worcester Foun~ation 
for Experimental Biology, edited by Ramwell, P.W. and Shaw, 
J.E. Wiley, Interscience, N.Y. pp 79-91 
Hynie, S., Krishna, G. and Brodie, B.B. (1966) Theophylline 
as a tool in studies of the role of cyclic adenosine 3',5'-
monophosphate in hormone-induced lipolysis. J. Pharmacal. 
Exp. Ther. 1], 90-96 
Karninen, Ei, Miettinen, M. and Karvaonen, M.J. (1962) Fat-
mobilizing activity of human fasting urine. Ann. Med. Exp. 
Biol. Fenniae (Helsinki) 40, 263-268 
Kekwick, A. and Pawan, G.L.S. (1963) An experimental approach 
to the mechanism of weight loss. II A comparison of effects 
of thyroxine, fat-mobilizing substance (FMS) and food depri-
vation on achieving weight loss in mice. Metabolism 1£, 
222-234 
Kekwick, A. and Pawan, G.L.S. (1964) The effect of high fat 
and high carbohydrate diets on rates of weight loss in mice. 
Metabolism 1], 87-97 
Kekwick, A. and Pawan, G.L.S. (1967) Fat-mobilizing substance (FNiS). Metabolism 16, 787-796 
Kekwick, A. and Pawan, G.L.S. (1968) Effect of fat-mobilizing 
substance in man. Lancet II, 198-199 
Kekwick, A. and Pawan, G.L.S. (1969) Body-weight, food and 
energy. Lancet 1, 822-825 
[ ______ _, 
f 
-99-
Klainer, L.M., Chi, Y.M., Freidberg, S.L., and Rall, T.W. and 
Sutherland, E.W. (1962) Adenyl cyclase. IV The effects of 
neurohormones on the formation of adenosine 3',5'-phosphate 
by preparations from brain and other tissues. J. Biol. Chern. 
m. 1239-1243 
Krishna, G., Weiss, B. and Brodie, B.B. (1968) A simple, 
sensitive method for the assay of adenyl cyclase. J. Pharmacal • 
. Exp. Ther. 1Ql, 379-385 
Kuo, J.F. and DeRenzo, E.C. (~969) A comparison of the effects 
of lipolytic and antilipolytic agents on adenosine 3',5'-mono-
phosphate levels in adipose cells as determined by prior 
labeling with adenine-8l4c, J. Biol. Chern. 244, 2252-2260 
Leboeuf, B. and Cahill, G.F.,Jr. 
adipose tissue. J. Biol. Chern. 
(1961) Studies on rat 
£i§.; 41-46 
Lepkovsky, S., Len, R., Koike, T. and Bouthilet, R. (1965) 
.Effects of protamine zinc insulin on chickens. Amer. J. Physiol. 
208, 589-592 
Louis, L.H., Minick, IVI.C. and Conn, J.W. (1960) Lipoatrophic 
diabetes: Isolation from urine of a potent adipokinetic sub-
stance. J. Lab. Clin. Med. ~. 924-925 
Louis, L.H. and Minick, M.C. (1962) Isolation of an insulin 
antagonist from urine of patients with lipoatrophic diabetes. 
J. Lab. Clin. Med. 60, 995-996 
Louis, L.H., Conn, J.W. and Minick, M.C. (1963) Lipoatrophic 
diabetes. Isolation and characterization of an insulin anta-
gonist from urine. fv'Ietabolism 12, 867-886 
Lynn, \'l.S., MacLeod, R.M. and Brown, R.H. (1960) Effects of 
epinephrine, insulin and corticotrophin on the metabolism of 
rat adipose tissue. J. Biol. Chern. ~. 1904-1911 
--100-
Mahadevan, s., Drillard, G.J. and Tappel, A.L. (1969) A 
modified colorimetric micro method for long-chain fatty acids 
and its application for assay of lipolytic enzymes. Anal. 
Biochem. £2, 387-396 
Mosinger, B. and Vaughan, M. (1969) Adenosine 3',5'-mono-
phosphate and regulation of lipolysis in rat adipose tissue. 
In Advances in Experimental Medicine and Biology-Drugs affecting 
~ipid Metabolism, edited by Hokes, W.L., Carlson, L.A. and 
Paoletti, R. Plenum Press, N.Y. pp 63-74 
Moskowitz, J. and Fain, J.N. (i970) Stimulation by growth 
hormone and dexamethasone of labeled cyclic adenosine. 3',5'-
monophosphate accumulation by white fat cells. J. Biol. Chern. 
245, 1101-1107 
Nathan, c. and LaRoche, C.L. (1970) 
d'origine hypophysaire. Path. Biol. 
Le facteur lipo-mobilisateur 
18, 765-773 
Nir, I., Dimick, M.K. and Lepkovsky, s. (1969) A fat-mobilizing 
substance in chicken urine. Can. J. Physiol. Pharmacol. ~. 
435-443 
Paoletti, R., Smith, R.L., Maickel, R.P. and Brodie, B.B. (1961) 
Identification and physiological role of norepinephrine in 
adipose tissue. Biochem. Biophys. Res. Comm. 5, 424-429 
Pawan, G.L.S. (1971) Fat mobilizing substance (FMS) and body 
fat metabolism in man. In Polypeptide Hormones, edited by 
Goth, E. and Fovenyi, J., Publishing House of the Hungarian 
Academy of Sciences, Budapest, Hungary. pp 177-183 
Raben, M.S., Landolt, R., Smith, F.A., Hoffman, K. and Yajima, 
H. (1961) Adipokinetic activity of synthetic peptides related 
to corticotrophin. Nature 189, 681-682 
Randle, P.J., Garland, P.B., Hales, C.N. and Newsholme, E.A. 
(1963) The glucose fatty-acid cycle. Its role in insulin 
sensitivity and the metabolic disturbance of diabetes mellitus. 
Lancet 1, 785-789 
-101-
Rizack, M.A. (1961) An epinephrine-sensitive lipolytic activity 
in adipose tissue. J. Biol. Chern. ~. 657-662 
Rizack, M.A. (1964) Activation of an epinephrine-sensitive 
lipolytic activity from adipose tissue by adenosine 3',5'-
phosphate. J. Biol. Chern. ~.392-395 
Rizack, M.A. (1965) Mechanism of hormonal control of adipose 
tissue lipase. Ann. N.Y. Acad. Sci. 1J1, _250-253 
Robison, G.A., Butcher, R.W. and Sutherland, E.W. (1971) 
Cyclic AIVIP. Academic Press, N.Y. pp 36-47 
Robison, G.A., Butcher, R.W. and Sutherland, E.W. (1971a) 
Cyclic AMP. Academic Press, N.Y. pp285-316 
Rodbell, M. (1964) Metabolism of isolated fat cells. I Effects 
of hormones on glucose metabolism and lipolysis. J. Biol. 
Chern. £12., 379-380 · 
Rudman, D., Reid, lVI.B., Seidman, F., DiGirolamo, M., Wertheim, 
A.R. and Bern, S. (1961) Purification and properties of a 
component of the pituitary gland which produces lipemia in the 
rabbit. Endocrinology 68, 273-280 
Seifter, J., Urivetsky, M. and Seifter, E. (1968) Lipid 
mobilizing peptide in hog pituitary and human urine. In AdvanceE 
in Experimental Medicine and Biqlogy-Pharmacology of Hormonal 
Polypeptides and Proteins,edited by Back, N., Martini, L. and 
Paoletti, R., Plenum Press, N.Y. pp 440-448 
Steinberg, D. (1971) Hormonal control of lipolysis in adipose 
·tissue. In Advances in Experimental Medicine and Biology-
Pharmacological Control of Lipid Metabolism, edited by Holmes, 
W.L., Paoletti, R. and Kritchevsky, D., Plenum Press, N.Y. 
pp 77-88 
Stevenson, J.A.F., Box, B.M. and Szlavko, A.J. (1964) A fat-
mobilizing and anorexigenic substance in the urine of fasting 
rats. Proc. Soc, Exp. BioL Me d. ill• 424-429 
-102-
Stevenson~ J.A.F. and Beaton, J.R. (1965) Fat-mobilizing 
substances from the urine of fasting animals. Ann. N.Y. 
Acad. Sci. 1J1, 189-198 
Tsai, S., Belfrage, P. and Vaughan, M. (1970) Activation of 
hormone-sensitive lipase in extracts of adipose tissue.· J. 
Lipid Res. 11, 466-472 
Vaughan, M. (1961) 
in adipose tissue. 
Effect of hormones on glucose metabolism 
J. Biol. Chern. ~. 2196-2199 
Vaughan, M. and Steinberg, D. (1963) Effect of hormones on 
lipolysis and esterification of free fatty acids during incubat-
ion of adipose tissue in vitro. J. Lipid Res. 4, 193-199 
Vaughan, M., Berger, J~E. and Steinberg, D. (1964) Hormone-
sensitive lipase and monoglyceride lipase activity in adipose 
tissue. J. Biol. Chern. ~. 401-409 
Weil, R. and Stetten, D. (1947) Urinary excretion of a fat-
mobilizing agent. J. Biol. Chern. 168, 129-132 
Weiss, B., Davies, J.I. and Brodie, B.B. (1966) Evidence for 
a role of adenosine 3',5'-monophosphate in adipose tissue 
lipolysis. Biochem. Pharmacal. 15, 1553-1561 
Weenink, R.(l969) A modified copper reagent for the colorimetric 
determination of free fatty acids. Clin. Chim. Acta 24, 
186-187 
-APPENDIX 
Dose (ug) 
25 
50 
Table 14 
Dose-Response Relationship between Lipolysis and FMS.at 
Different Stages of Purification* 
Crude 
FMS 
-
-
PM-10 
Filtrate 
-
-
UM-2 
Residue 
-
0.80:!: 0.02 
FIV'!S 
0.60 + 0.01 
1.40 .± 0.12 
I 
75 1.92:!: 0.04 ....... - - - 0 
+ 
100 . 0.20 + 0.01 0.65 + 0.02 1.58.+ 0.08 2.62 + 0.05 
125 
- - -
J.21 + 0.11 
150 
- -
2.50 .± 0.10 
200 0 • .36 + 0.04 1.29 .± 0.01 J.04 + 0 • .32 
.300 0.70 + 0.10 1. 94 :!: 0 • 0.3 
400 0.80 .± 0.06 2.59 .± 0.04 
*Lipolytic activity in vitro is expressed in terms of the increased release (umoles) 
of free fatty acids (FFA) over that observed in the absence of added FMS preparations 
during the course of .3 hours incubation. All data points represent the mean :!: 
standard deviation of five determinations. Portions of the above table are 
represented in Figure 5. 
I 
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Table 15 
Cyclic AMP Formation and Lipolysis of Labeled Adipose 
Cells Incubated with FMS 
Dose of FMS (ug) 
0 
25 
50 
100 
200 
300 
Adenyl Cyclase* 
Activity 
0 
9·3 + 4.4*** 
29.1! 11.7 
58.1! 16.6 
85.9! 6.J 
100. 
Lipolysis** 
0 
0.025 + 
. -
O.OJO*** 
0.008 + 0.010 
-
0.050 + 0.063 
0.100 + 0.080 
-
0.250 + 0.120 
-
*Adenyl cyclase activity is expressed as the percentage of the 
accumulation of the labeled cyclic AMP in the incubation medium 
produded by 300 ug of FMS 
**Lipolysis is determined by measuring the free fatty acids 
(umoles) released over that in the absence of FMS 
***Mean ± standard deviation, three determinations 
Note: Portions of the above table are represented in Figure 8. 
r 
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Table 16 
Cyclic AMP Formation and Lipolysis of Labeled Adipocytes 
Incubated with 100 ug of FMS for Various Periods of Time 
Time (Min.) 
0 
5 
10 
15 
20 
JO 
45 
60 
120 
180 
Adenyl Cyclase~.~­
Activity 
0 
15.9 + 1.2*** 
55.1 + 6".) 
6).9 + 0.6 
100 
38.4 + l. 6 
16.7 + 0.2 
-
0 
0 
0 
Lipolysis-~* 
0 
0 
0.05 + o. o6-::·** 
0.05! O.OJ 
0.05 + 0.04 
0.2) ! 0.02 
0. 30 ! 0.01 
0.51 + 0.01 
1.)7 + O.OJ 
2.49 + 0.02 
-
*Adenyl cyclase activity is expressed as the percentage of the 
accumulation of the labeled cyclic AMP in the medium produced 
by an incubation time of 20 minutes. 
**Lipolysis is determined by measuring the free fatty acids 
(umoles) released over that in the absence of added FMS. 
***Mean + standard deviation, three separate determinations 
Note1 Portions of the above table are represented in Figure 11. 
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Table 17 
Dose-Response Relationship between FMS and Lipolysis 
FMS (ug) 
25 
50. 
75 
100 
125 
No. of 
Determinations 
5· 
5 
5 
5 
5 
Lipolysis* 
0.60 + 0.01** 
1.40 + 0.12 
1.92 + 0.04 
-
2.62 + 0.05 
-
).21! 0.11 
*Lipolysis is determined by measuring the free fatty acids 
(umoles) released over that in the absence of added FMS. 
**Mean ! standard deviation 
Note: Portions of the above table are represented in Figure 12 
and Ta ble 14. 
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Table 18 
Dose-Response Relationship Between Theophylline and Lipolysis 
No. of 
Determinations Theophylline (m~) Lipolys is1~ 
0.10 5· 0.05!. o. o4-:~o-l!-
0.25 5 0.20 + 0.10 
0.50 5 0.40 + 0.14 
-
0.75 5 0.86 + 0.17 
-
1.00 5 1.44 + 0.24 
-
1.25 5 1.90 + 0.25 
1. 50 5. 2.J6 + 0.21 
1.75 5 2.70 + 0.11 
2.00 5 2.80 + 0.07 
*Lipolysis is determined by measuring the free fatty acids 
(umoles) released over that in the absence of added theophylline. 
**Mean + standard deviation 
Note: Portions of the above table are represented in Figure 1.3. · 
ABSTRACT 
Abstract of the dissertation entitled "FAT-MOBILIZING 
SUBSTANCE (FMS) AND LIPOLYSIS" submitted by Roderic P. Kwok 
in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy, February, 19?4. 
A Fat-Mobilizing Substance (FMS) has been prepared from 
the urine of fasting rats by a three-stage extraction procedure 
involving benzoic acid precipitation, water extraction and 
alcoholic precipitation. Factors that influence the excretion 
of FMS were studied. It was found that the excretion of FMS 
was increased after feeding the animals a high fat diet, whereas 
prior feeding with a high carbohydrate diet reduced its excretio • 
FMS was excreted in the greatest amount in the first 24 hours 
of the fasting period. Decreasing the environmental temperature 
of the animals during the urine collection period from 30° to 
5°C resulted in a progressively increased excretion of FMS to a 
maximum at 15°C. 
· In vitro, FMS has the ability to increase the release of 
free fatty acids from epididymal fat pads into a medium contain-
ing bovine serum albumin and this parameter has been taken as 
the index for measuring the in vitro lipolytic activity of 
FMS. For this purpose, it was found useful to employ epididymal 
adipose tissue from rats previously maintained on a high carbo-
hydrate diet and fasted for 72 hours at 5°C. 
FMS appears to be protein in nature with a molecular 
weight between 5,000 and 10,000 and is inactivated by heat 
and digestion with trypsin. It was purified by ultrafiltration 
and column chromatography with Sephadex G-50 and Bio-Gel P-10. 
When subjected to electrophoresis on cellulose acetate and 
polyacrylamide gel, this material migrated as a single protein 
spot. 
Investigation of FlVIS with labeled isolated fat cells 
indicates strongly that cyclic AMP plays an important role in 
lipolysis promoted by FMS. Incubation of labeled isolated fat 
;> 
cells for a brief period of time with increasing concentration 
of FMS resulted in increased cyclic AMP levels without a signi-
ficant increase in lipolysis. When longer incubation times were 
employed, lipolysis was observed and it occurred after the 
maximal stimulation of the adenyl cyclase. The fact that cyclic 
AMP levels were elevated before lipolysis was detected in cells 
treated with FMS is consistent with the current theory that 
cyclic AMP is the·cellular mediator of "hormone" actions. 
Theophylline, an inhibitor of phosphodiesterase which 
hydrolyzes cyclic AMP, acts synergistically with FMS in vitro. 
While neither 0.25 mM theophylline nor 25ug of FiviS strongly 
stimulated lipolysis, the combination of the two produced a 
striking response. The potentiation of FMS by theophylline 
can be taken as good presumptive evidence that FMS acts by 
stimulating adenyl cyclase. 
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